Exhibit 2.4
EXECUTION COPY
SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
THIS SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this
"AGREEMENT") is entered into as of February 8, 2002 by and among InSight Health
Services Holdings Corp., a Delaware corporation (the "COMPANY"), the JWC Holders
(as defined below), the Halifax Holders (as defined below), the Management
Holders (as defined below) and the Additional Holders (as defined below).
RECITALS
A. As a result of the consummation of the transactions contemplated by
the Agreement and Plan of Merger, dated as of June 29, 2001 (the "MERGER
AGREEMENT"), and of certain related transactions to be consummated concurrently
therewith, the Stockholders (as defined below) own (and may hereafter acquire)
certain shares of Common Stock (as defined below) and certain options, warrants,
securities and other rights to acquire from the Company, by exercise,
conversion, exchange or otherwise, shares of Common Stock or securities
convertible into Common Stock.
B. The Stockholders entered into that certain Stockholders Agreement
dated as of June 29, 2001, which was superceded by that certain Amended and
Restated Stockholders Agreement dated as of October 17, 2001 (the "Existing
Agreement") for the purpose of regulating certain aspects of the Stockholders'
relationships with one another and with the Company.
C. All of the Stockholders now desire to amend and restate the Existing
Agreement in the manner set forth below.
AGREEMENT
In consideration of the premises and the mutual promises,
representations, warranties, covenants and conditions set forth in this
Agreement, the receipt and sufficiency of which are acknowledged by all parties
to this Agreement, the parties to this Agreement mutually agree as follows:
ARTICLE I
Definitions
For the purposes of this Agreement, the following terms shall be
defined as follows:
"ACTIVE TRADING MARKET" shall mean the New York or American Stock
Exchange or the National Association of Securities Dealers, Inc.'s National
Market System or Small Capitalization System.
1
"ADDITIONAL HOLDERS" shall mean those Persons listed as Additional
Holders on the signature pages hereof and all Persons that became Stockholders
as of the date hereof and are designated as Additional Holders pursuant to
Section 2.13 hereof.
An "AFFILIATE" of a specified Person shall mean a Person who, directly
or indirectly, through one or more intermediaries, controls or is controlled by
or is under common control with the specified Person and, when used with respect
to the Company or any Subsidiary of the Company, shall include any holder of
capital stock holding greater than 5% of the total number of outstanding shares
of Common Stock of the Company on a fully-diluted basis or any officer or
director of the Company or any Subsidiary of the Company.
"BOARD OF DIRECTORS" shall mean the Board of Directors of the Company.
"BUSINESS DAY" shall mean any day, other than a Saturday, Sunday or
legal holiday, on which banks in New York, New York and Boston, Massachusetts
are permitted to be open for business.
"CALL EVENT" shall have the meaning set forth in Section 2.5(a).
"CALL GROUP" shall have the meaning set forth in Section 2.5(a).
"CALL OPTION" shall have the meaning set forth in Section 2.5(a).
"CALL PRICE" shall mean, as of any date, with respect to any Subject
Securities, a per share price equal to (a) the quotient of (i) the excess of (A)
the product of 5.25 times EBITDA, over (B) the aggregate amount of the
Consolidated Indebtedness as of the end of the period for which EBITDA is
calculated, plus (C) the amount of cash and cash equivalents of the Company and
its Subsidiaries as of the end of the period for which EBITDA is calculated
which is not required to fund the day-to-day operations of the Company and its
Subsidiaries as reasonably determined by the Board of Directors in good faith,
divided by (ii) the aggregate number of Common Stock Equivalents at the time of
the relevant Call Event or Put Event, as applicable, outstanding, minus, (b) in
the case of Vested Options, the per share exercise price payable in connection
with such Vested Options.
"CALL SECURITIES" shall have the meaning set forth in Section 2.5(a).
"CAUSE," with respect to a Management Holder, shall have the meaning
attributed to it under the executed written employment agreement between such
Management Holder and the Company (or a Subsidiary thereof) or, in the absence
of such employment agreement, "CAUSE" shall mean the occurrence of any of the
following during the term of such Management Holder's employment with the
Company (or a Subsidiary thereof):
(a) such Management Holder has performed his duties negligently;
2
(b) such Management Holder is guilty of misconduct in
connection with the performance of such Management Holder's duties;
(c) such Management Holder has committed any serious crime or
offense;
(d) such Management Holder has failed or refused to comply
with the oral or written policies or directives of the Board of Directors; or
(e) such Management Holder has breached any provision or
covenant contained in this Agreement.
"COMMON STOCK" shall mean shares of Common Stock, par value $0.001 per
share, of the Company.
"COMMON STOCK EQUIVALENTS" shall mean, as of any date, (a) all shares
of Common Stock outstanding as of such date and (b) all Vested Options,
convertible securities, warrants and other securities convertible, exchangeable
into or redeemable for Common Stock, which securities are vested and/or
exercisable within 60 days of the date of measurement. Solely for the purposes
of Section 2.4, Common Stock Equivalents shall mean all shares of Common Stock
and all options, convertible securities, warrants and other securities
convertible, exchangeable into or redeemable for Common Stock, whether or not
vested and/or exercisable.
"COMPANY CALL PERIOD" shall have the meaning set forth in Section
2.5(a)(i).
"COMPANY EXCLUSIVE FIRST REFUSAL PERIOD" shall have the meaning set
forth in Section 2.2(a).
"COMPETITOR " shall mean any existing or new firm that competes with
the Company in any activity in which the Company is currently engaged, or has
plans to be engaged in the future as disclosed or discussed at the meetings of
the Board of Directors.
"CONSOLIDATED INDEBTEDNESS" shall mean, as of any date, the aggregate
amount outstanding, on a consolidated basis, of (a) all obligations of the
Company or its Subsidiaries for borrowed money, (b) all obligations of the
Company or its Subsidiaries evidenced by bonds, debentures, notes or other
similar instruments or upon which interest charges are customarily paid, (c) all
obligations of the Company or its Subsidiaries for the deferred purchase price
of property or services, except current accounts payable arising in the ordinary
course of business and not overdue beyond such period as is commercially
reasonable for the Company or its Subsidiaries' business, (d) all obligations of
the Company or its Subsidiaries under conditional sale or other title retention
agreements relating to property purchased by such Person and all capitalized
lease obligations, (e) all payment obligations of the Company or its
Subsidiaries on or for currency protection agreements, (f) all obligations of
the Company or its Subsidiaries as an account party under any letter of credit
(excluding those supporting trade payables), (g) all obligations of any third
party secured by property
3
or assets of the Company or its Subsidiaries (regardless of whether or not such
Person is liable for repayment of such obligations) and (h) all guarantees of
the Company or its Subsidiaries.
"COST PRICE" shall mean, with respect to any Subject Securities, the
purchase price, if any, per share of Common Stock or per Vested Option, as the
case may be, paid to the Company for such Subject Securities by the original
holder thereof or, if no shares were so purchased at the Closing (as defined in
the Merger Agreement), then the price per share paid by the JWC Holders;
provided that the Cost Price with respect to (i) Common Stock issued to the
Management Holders pursuant to an exercise of options granted under the
Company's 2001 Stock Option Plan shall equal $18.00 per share and (ii) options
granted to the Management Holders under the Company's 2001 Stock Option Plan
shall equal to $9.63 per share. If at any time the number of shares of Common
Stock outstanding is (a) increased by a stock dividend payable in shares of
Common Stock or by a subdivision or split-up of shares of Common Stock or (b)
decreased by a combination of shares of such Common Stock, the Cost Price per
share of Common Stock shall be adjusted upward or downward, as appropriate, to
reflect the decrease or increase in shares of Common Stock outstanding.
"DESIGNATED EMPLOYEE" shall have the meaning set forth in Section
2.5(c).
"DISABLED," with respect to a Management Holder, shall have the meaning
attributed to it under the executed written employment agreement between such
Management Holder and the Company (or a Subsidiary thereof) or, in the absence
of such employment agreement, such Management Holder shall be deemed to have
become "DISABLED" if, during the term of such Management Holder's employment
with the Company (or a Subsidiary thereof), such Management Holder shall become
physically or mentally disabled, whether totally or partially, either
permanently or so that such Management Holder, in the good faith judgment of the
Board of Directors, is unable substantially and competently to perform his
duties on behalf of the Company for a period of 90 consecutive days or for 90
days during any six month period during the said term of employment. In order to
assist the Board of Directors in making that determination, such Management
Holder shall, as reasonably requested by the Board of Directors, (i) make
himself available for medical examinations by one or more physicians chosen by
the Board and (ii) grant to the Board of Directors and any such physicians
access to all relevant medical information concerning him, arrange to furnish
copies of his medical records to the Board of Directors and use his best efforts
to cause his own physicians to be available to discuss his health with the Board
of Directors.
"DRAGALONG GROUP" shall have the meaning set forth in Section 2.4.
"EBITDA" shall mean consolidated earnings of the Company and its
Subsidiaries, including equity in the earnings from non-consolidated
subsidiaries, before interest, taxes, depreciation, amortization and the
management fee paid to JWC Inc., Halifax Capital Partners or any of their
respective Affiliates and after deduction of all operating expenses, minority
interests expenses and incentive compensation, all as calculated in accordance
with GAAP consistently applied, as reflected in the Company's most recently
available audited consolidated financial statements for the immediately
preceding fiscal year.
4
"EXCLUDED SECURITIES" shall have the meaning set forth in Section
4.1(e).
"EXCHANGE ACT" shall mean the Securities Exchange Act of 1934, as
amended, or any successor federal statute thereto, and the rules and regulations
of the SEC promulgated thereunder, all as the same shall be in effect from time
to time.
"GAAP" shall mean the generally accepted accounting principles in the
United States of America, as such principles are changed from time to time,
consistent with those applied in the preparation of the financial statements of
such Person.
"GOOD REASON," with respect to a Management Holder, shall have the
meaning attributed to it under the executed written employment agreement between
such Management Holder and the Company (or a Subsidiary thereof) or, in the
absence of such employment agreement, "GOOD REASON" shall be deemed to have
occurred if, other than for Cause, any of the following has occurred during the
term of such Management Holder's employment with the Company (or a Subsidiary
thereof):
(a) such Management Holder's base salary has been reduced,
other than in connection with a reduction of executive compensation imposed by
the Board of Directors in response to negative financial results or other
adverse circumstances affecting the Company or its Subsidiaries; or
(b) the Company has reduced or reassigned, in any material
respect, the duties of such Management Holder as an employee of the Company and
such event has not been rescinded within 10 business days after such Management
Holder notifies the Company in writing that he objects thereto.
"HALIFAX AFFIRMATIVE BOARD VOTE" shall have the meaning set forth in
Section 4.2.
"HALIFAX CAPITAL PARTNERS" shall mean Halifax Capital Partners, L.P., a
Delaware limited partnership.
"HALIFAX DIRECTOR" shall have the meaning set forth in Section 4.1(c).
"HALIFAX HOLDER" shall mean each of those Persons listed as Halifax
Holders on the signature pages hereof and, after the date hereof, shall mean all
such Persons and Permitted Transferees of the Halifax Holders, other than those
transferees who qualify as JWC Holders or Management Holders immediately prior
to or upon such Transfer.
"HALIFAX REPRESENTATIVE" shall have the meaning set forth in Section
6.9.
"HOLDER" shall have the meaning set forth in Section 3.1.
"INITIATING STOCKHOLDER" shall have the meaning set forth in Section
2.3(a).
5
"INVOLUNTARY TRANSFER" shall have the meaning set forth in Section 2.9.
"INVOLUNTARY TRANSFER NOTICE" shall have the meaning set forth in
Section 2.9.
"INVOLUNTARY TRANSFEREE" shall have the meaning set forth in Section
2.8.
"JOINDER AGREEMENT" shall mean a joinder agreement substantially in the
form of Exhibit B attached hereto which is entered into pursuant to Section 2.13
hereof.
"JWC EQUITY PARTNERS II" shall mean X.X. Childs Equity Partners II,
L.P., a Delaware limited partnership.
"JWC HOLDERS" shall mean each of those Persons listed as JWC Holders on
the signature pages hereof and, after the date hereof, shall mean all such
Persons and Permitted Transferees of the JWC Holders, other than those
transferees who qualify as Halifax Holders or Management Holders immediately
prior to or upon such Transfer.
"JWC INC." shall mean X.X. Childs Associates, Inc., a Delaware
corporation.
"JWC REPRESENTATIVE" shall have the meaning set forth in Section 6.8.
"LIEN" shall mean any lien, mortgage, pledge, security interest (as
defined in the New York Uniform Commercial Code), claim or other type of charge
or encumbrance of any kind, or any other type of preferential arrangement,
including, without limitation, the lien or retained security title of a
conditional vendor and any easement, right of way or other encumbrance on title
to real property and any financing statement filed in respect of any of the
foregoing.
"MANAGEMENT HOLDERS" shall mean any Person listed as a Management
Holder on the signature pages hereof and shall also include (a) any director,
officer or employee of the Company or any of its Subsidiaries who hereafter
becomes a Stockholder and (b) Permitted Transferees of the Management Holders,
unless immediately prior to such Transfer such transferee was a JWC Holder or a
Halifax Holder.
"MATERIAL TRANSACTION" means any material transaction in which the
Company or any of its Subsidiaries proposes to engage or is engaged, including a
purchase or sale of assets or securities, financing, merger, consolidation,
tender offer or any other transaction that would require disclosure pursuant to
the Exchange Act, and with respect to which the Board of Directors reasonably
has determined in good faith that compliance with this Agreement may reasonably
be expected to either materially interfere with the Company's or such
Subsidiary's ability to consummate such transaction in a timely fashion or
require the Company to disclose material, non-public information prior to such
time as it would otherwise be required to be disclosed.
"MERGER AGREEMENT" shall have the meaning set forth in Recital A.
6
"OFFER PERIOD" shall have the meaning set forth in Section 2.2(a).
"OFFERED SECURITIES" shall have the meaning set forth in Section
5.1(a).
"OFFEREE PERCENTAGE" shall mean, as to each offeree, the fraction,
expressed as a percentage, the numerator of which is the total number of shares
of Common Stock Equivalents held by such offeree, and the denominator of which
is the total number of shares of Common Stock Equivalents held by all of the
offerees.
"OFFEROR" shall have the meaning set forth in Section 2.2(a).
"ORIGINAL HALIFAX HOLDERS" shall mean the Halifax Holders as of the
date of this Agreement.
"ORIGINAL JWC HOLDERS" shall mean the JWC Holders as of the date of
this Agreement.
"ORIGINAL MANAGEMENT HOLDERS" shall mean the Management Holders as of
the date of this Agreement.
"PARTICIPATING OFFEREES" shall have the meaning set forth in Section
2.4(a).
"PARTICIPATION NOTICE" shall have the meaning set forth in Section
2.4(a).
"PARTICIPATION SECURITIES" shall have the meaning set forth in Section
2.4(a).
"PERMITTED TRANSFER" shall mean a Transfer that is not a Prohibited
Transfer and is one of the following:
(a) a Transfer of any Subject Securities between any JWC
Holder, Halifax Holder or Management Holder and such Stockholder's spouse,
children (whether natural, step or by adoption), grandchildren (whether natural,
step or by adoption) or parents or to a trust, partnership or limited liability
company solely for the benefit of one or more of any of such Persons;
(b) a Transfer of Subject Securities by a JWC Holder to JWC
Inc. or JWC Equity Partners II or to the limited partners, co-investors,
officers, employees or consultants of JWC Inc. or JWC Equity Partners II or to a
corporation or corporations or to a partnership or partnerships, limited
liability company or companies (or other entity for collective investment, such
as a fund) which is (and continues to be) an Affiliate of or controlled by,
controlling or under common control with JWC Inc. or JWC Equity Partners II
(other than the Company and its Subsidiaries);
(c) a Transfer of Subject Securities by a Halifax Holder to
Halifax Capital Partners or to the limited partners, co-investors, officers,
employees or consultants of Halifax Capital Partners or to a corporation or
corporations or to a partnership or partnerships, limited liability company or
companies (or other entity for collective investment, such as a fund) which is
(and
7
continues to be) an Affiliate of or controlled by, controlling or under common
control with Halifax Capital Partners;
(d) a Transfer of Subject Securities between or among the JWC
Holders or the Halifax Holders;
(e) a Transfer of Subject Securities between any Stockholder
who is a natural person and such Stockholder's guardian or conservator;
(f) a bona fide pledge of Subject Securities by a JWC Holder
or a Halifax Holder to a bank or financial institution; and
(g) a Transfer of Subject Securities by a JWC Holder or a
Halifax Holder to a Management Holder who is not an Affiliate (other than as an
officer, employee, director or stockholder of the Company and its direct or
indirect Subsidiaries) of JWC Inc. or Halifax Capital Partners.
No Permitted Transfer shall be effective unless and until the transferee of the
Subject Securities so transferred executes and delivers to the Company an
executed Joinder Agreement in accordance with Section 2.13 hereof; provided,
however, that the Permitted Transfer to a bank or a financial institution
pursuant to clause (e) above shall be effective upon delivery of the Subject
Securities and such entity shall not execute and deliver an executed Joinder
Agreement in accordance with Section 2.13 hereof unless and until foreclosure or
similar action by any such pledgee.
"PERMITTED TRANSFEREE" shall mean, with respect to any Stockholder, any
Person who shall have directly or indirectly acquired and who shall hold any
Subject Securities pursuant to a Permitted Transfer from that Stockholder.
Notwithstanding the foregoing, a Permitted Transferee shall not include any
Person that is in receivership, bankruptcy, insolvency, dissolution, liquidation
or any similar proceeding or any Person whose incompetence has been established
pursuant to a judicial determination.
"PERSON" shall mean an individual, corporation, partnership, limited
liability company, trust, unincorporated association, government or any agency
or political subdivision thereof, or any other entity.
"PREEMPTIVE OFFER" shall have the meaning set forth in Section 5.1(a).
"PREEMPTIVE OFFER ACCEPTANCE NOTICE" shall have the meaning set forth
in Section 5.1(b).
"PREEMPTIVE OFFER PERIOD" shall have the meaning set forth in Section
5.1(a).
"PRIMARY SHARES" shall mean at any time the authorized but unissued
shares of Common Stock or shares of Common Stock held by the Company in its
treasury.
8
"PROHIBITED TRANSFER" shall mean any Transfer of any Subject Security
to a Person which (a) may not be effected without registering the securities
involved under the Securities Act of 1933, as amended, (b) would result in the
assets of the Company constituting "Plan Assets" as such term is defined in the
Department of Labor regulations promulgated under the Employee Retirement Income
Security Act of 1974, as amended, (c) would cause the Company to be, be
controlled by, or be under common control with an "investment company" for
purposes of the Investment Company Act of 1940, as amended, (d) would require
any securities of the Company to be registered under the Exchange Act, (e) is a
Competitor of the Company (other than Transfers in accordance with Section 2.4)
or (f) is in violation of this Agreement.
A "PUBLIC OFFERING" shall mean the completion of a sale of shares of
Common Stock pursuant to a registration statement which has become effective
under the Securities Act, excluding a registration form relating solely to
employee benefit plans, or on a registration form which does not permit
secondary sales or does not include substantially the same information as would
be required in a Form S-1 or Form S-3 Registration Statement (or any successor
forms) covering the sale of Registrable Securities.
"PUT NOTICE" shall have the meaning set forth in Section 2.6(a).
"PUT OPTION" shall have the meaning set forth in Section 2.6(a).
"PUT PERIOD" shall have the meaning set forth in Section 2.6(a).
"PUT PRICE" shall mean, as of any date, with respect to any Subject
Securities, a per share price equal to (a) the quotient of (i) the excess of (A)
the product of 4.75 times EBITDA, over (B) the aggregate amount of the
Consolidated Indebtedness as of the end of the period for which EBITDA is
calculated, plus (C) the amount of cash and cash equivalents of the Company and
its Subsidiaries as of the end of the period for which EBITDA is calculated
which is not required to fund the day-to-day operations of the Company and its
Subsidiaries as reasonably determined by the Board of Directors in good faith,
divided by (ii) the aggregate number of Common Stock Equivalents at the time of
the relevant Call Event or Put Event, as applicable, outstanding, minus, (b) in
the case of Vested Options, the per share exercise price payable in connection
with such Vested Options.
"PUT SECURITIES" shall have the meaning set forth in Section 2.6(a).
"REFUSED SECURITIES" shall have the meaning set forth in Section
5.1(c).
"REGISTRABLE SECURITIES" shall mean, as of any date, with respect to
any Stockholder, (a) all shares of Common Stock held by such Stockholder as of
such date and (b) all shares of Common Stock that may be acquired as of such
date by such Stockholder upon exercise of Vested Options;
9
provided that, as to any particular Registrable Security, such security shall
cease to be a Registrable Security when (i) a registration statement (other than
a registration statement on Form S-8) with respect to the sale or exchange of
such security shall have become effective under the Securities Act and such
security shall have been disposed of in accordance with such registration
statement, (ii) a registration statement on Form S-8 with respect to such
security shall have become effective under the Securities Act, (iii) such
security shall have been sold or acquired in a Rule 144 Transaction, or (iv)
such security (once issued) has ceased to be outstanding.
"RULE 144 TRANSACTION" means a transfer of Common Stock complying with
Rule 144 under the Securities Act as such rule or a successor thereto is in
effect on the date of such transfer.
"SALE REQUEST" shall have the meaning set forth in Section 2.4.
"SCHEDULE OF STOCKHOLDERS" shall refer to the Schedule of Stockholders
attached hereto as EXHIBIT A.
"SEC" shall mean the Securities and Exchange Commission or successor
agency or commission of the United States federal government.
"SECURITIES ACT" shall mean the Securities Act of 1933, as amended, or
any successor federal statute thereto, and the rules and regulations of the SEC
promulgated thereunder, all as the same shall be in effect from time to time.
"STOCKHOLDER" shall mean any party hereto other than the Company,
including any Person who hereafter becomes a party to this Agreement pursuant to
Section 2.13 hereof.
"STOCKHOLDER GROUP" shall mean any of (a) the JWC Holders, taken as a
group, (b) the Halifax Holders, taken as a group, (c) the Management Holders,
taken as a group, and/or (d) the Additional Holders, taken as a group. The
Company shall not in any case be deemed to be a member of any Stockholder Group
(whether or not the Company holds or repurchases any Common Stock Equivalents).
"STOCK OPTION AGREEMENT" shall mean any stock option agreement between
the Company and an employee thereof.
"SUBJECT SECURITIES" shall mean any Common Stock or Common Stock
Equivalents now or hereafter held by any Stockholder.
"SUBSIDIARY" with respect to any Person (the "PARENT") shall mean any
Person of which such parent, at the time in respect of which such term is used,
(a) owns directly or indirectly more than 50% of the equity or beneficial
interest, on a consolidated basis, or (b) owns directly or controls with power
to vote, indirectly through one or more Subsidiaries, shares of capital stock or
beneficial interest having the power to cast at least a majority of the votes
entitled to be cast for the election of directors, trustees, managers or other
officials having powers analogous to those of directors of
10
a corporation. Unless otherwise specifically indicated, when used herein, the
term Subsidiary shall refer to a direct or indirect Subsidiary of the Company.
"THIRD PARTY" shall mean any Person other than the Company.
"TRANSFER" shall mean to transfer, sell, assign, pledge, hypothecate,
give, grant or create a security interest in or Lien on, place in trust (voting
or otherwise), assign an interest in or in any other way encumber or dispose of,
directly or indirectly and whether or not by operation of law or for value, any
of the Subject Securities.
"TRANSFER NOTICE" shall have the meaning set forth in Section 2.2(a).
"TRANSFER OFFER" shall have the meaning set forth in Section 2.2(a).
"TRANSFER STOCK" shall have the meaning set forth in Section 2.2(a).
"TRANSFERRED SECURITIES" shall have the meaning set forth in Section
2.8.
"UNMATURED SHARES" shall have the meaning set forth in Section 2.5(f).
"VESTED OPTIONS" shall mean, as of any date, options, securities and
other rights to acquire from the Company, by exercise, conversion, exchange or
otherwise, shares of Common Stock or securities convertible into Common Stock,
which are vested and exercisable within 60 days of such date of measurement.
"VOTING STOCK" shall mean the Common Stock, Common Stock Equivalents
and any other securities of the Company entitled to vote at a meeting of the
Stockholders, including, but not limited to, with respect to the election of the
Board of Directors.
ARTICLE II
Rights With Respect To The Subject Securities
2.1 Limited Rights of Transfer.
(a) Transfers. Except for the JWC Holders, no Stockholder
shall Transfer all or any part of the Subject Securities at the time held by
such Stockholder. Subject to Section 2.1(b), no Transfer of or attempt to
Transfer any Subject Securities in violation of the preceding sentence shall be
effective or valid for any purpose. No Transfer of any Subject Securities shall
be effective or valid under this Section 2.1(a) if such Transfer constitutes a
Prohibited Transfer, or unless and until the transferee executes and delivers to
the Company a Joinder Agreement in accordance with Section 2.13 hereof.
11
(b) Exceptions. Notwithstanding Section 2.1(a), a Transfer may
be effectively and validly made hereunder if such Transfer is not a Prohibited
Transfer and is either (i) a Permitted Transfer, (ii) made pursuant to the
registration rights granted under Article III hereof, (iii) made pursuant to
and/or following a Public Offering, (iv) made pursuant to Sections 2.2, 2.3 (as
a Participating Offeree), 2.4 or 2.5 or (v) made with the written consent of the
holders of a majority of the Common Stock Equivalents at the time held by the
JWC Holders (or the JWC Representative) and the holders of a majority of the
Common Stock Equivalents at the time held by the Halifax Holders (or the Halifax
Representative). No Transfer of any Subject Securities shall be effective or
valid under this Section 2.1(b) if such Transfer constitutes a Prohibited
Transfer. In addition, no Transfer shall be effective or valid under this
Section 2.l(b) unless and until the transferee executes and delivers to the
Company a Joinder Agreement in accordance with Section 2.13 hereof.
2.2 Right of First Refusal.
(a) Notice of Offer. If (i) at any time any Halifax Holder,
Management Holder, Additional Holder or any of their Permitted Transferees (the
"OFFERING HOLDER") receives a bona fide offer to purchase any or all of such
Offering Holder's Subject Securities (the "TRANSFER STOCK") from any Third Party
(other than to a Permitted Transferee) (the "OFFEROR") and (ii) such Offering
Holder wishes to accept such offer (a "TRANSFER OFFER"), then the Offering
Holder shall cause the Transfer Offer to be reduced to writing and shall provide
a notice containing the offer to purchase specified below (the "TRANSFER
NOTICE") to the Company and all other Stockholders. The Transfer Notice shall be
accompanied by a true and correct copy of the Transfer Offer (which shall
identify in reasonable detail all material terms, including, but not limited to,
the Offeror, the Transfer Stock, the price contained in the Transfer Offer and
all the other terms and conditions of the Transfer Offer). The Transfer Notice
shall constitute an irrevocable offer to sell any or all of the Transfer Stock
to the Company and to all other Stockholders within 30 days of receipt by the
Company of the Transfer Notice (the "OFFER PERIOD"). During the Offer Period,
subject to the limitation in the next sentence, any combination of the Company
and/or the other Stockholders will have the right and option to purchase all of
the Transfer Stock at a price equal to the price contained in the Transfer Offer
and upon the same terms as contained in the Transfer Offer. During the first 15
days of the Offer Period (the "COMPANY EXCLUSIVE FIRST REFUSAL PERIOD"), the
Company shall have the exclusive right and option to purchase all of the
Transfer Stock. Following the expiration of the Company Exclusive First Refusal
Period, if the Company has not opted to purchase all of the Transfer Stock, the
Company and any combination of the other Stockholders may purchase all of the
Transfer Stock. For the avoidance of doubt, unless the Offering Holder shall
have consented to the purchase of less than all of the Transfer Stock by the
Company and/or the other Stockholders, neither the Company nor any Stockholder,
nor any combination of the Company and any Stockholder may purchase any Transfer
Stock pursuant to the foregoing provisions unless all of the Transfer Stock is
to be so purchased (whether by the Company, the other Stockholders, or any
combination thereof). Notwithstanding any other provision of this Agreement,
unless otherwise agreed to by at least 50% of the Subject Securities held by the
JWC Holders and 50% of the Subject Securities held by the Halifax Holders, no
Management Holder or Additional Holder may Transfer their Subject Securities in
exchange for consideration other than cash.
12
(b) Closing of Transfer Stock. If, during the Offer Period,
the Company, or any combination of the Company and the other Stockholders, has
accepted the offer contained in the Transfer Notice, the closing of the purchase
of such Transfer Stock shall take place at the principal offices of the Company
within 10 days of such acceptance. At such closing, the Company and/or the other
Stockholders, as applicable, and/or its or their designees, as the case may be,
shall deliver a certified check or checks calculated at the price set forth in
the Transfer Notice to the Offering Holder against delivery of certificates
and/or other instruments representing the Transfer Stock, together with stock or
other appropriate powers duly endorsed with respect to the Transfer Stock, free
and clear of all Liens (other than pursuant to securities laws, this Agreement
or a Stock Option Agreement). All of the foregoing deliveries will be deemed to
be made simultaneously and none shall be deemed completed until all have been
completed.
(c) Completion of Sale to Third Party. If, during the Offer
Period, neither the Company nor any combination of the Company and the other
Stockholders has accepted the offer contained in the Transfer Notice in writing
as to all the Transfer Stock covered thereby, or within 15 days of acceptance by
any combination of the Company and any Stockholder the closing has not occurred,
and Section 2.4 does not apply to such Transfer, then during the next 60 days,
the Offering Holder may sell the Transfer Stock to the Offeror at the price and
on the other terms contained in the Transfer Notice. No sale may be made by the
Offering Holder to any Offeror if such sale would constitute a Prohibited
Transfer or unless and until such Offeror executes and delivers to the Company a
Joinder Agreement in accordance with Section 2.13 hereof. Promptly after any
sale pursuant to this Section 2.2, the Offering Holder shall furnish such
evidence of the completion (including time of completion) of such sale and of
the terms thereof as the Company may reasonably request. If the Offering Holder
has not completed the sale of the Transfer Stock during the applicable period
referred to above, such Offering Holder shall no longer be permitted to sell
such shares pursuant to this Section 2.2 without again fully complying with the
provisions of this Section 2.2 and all the restrictions on sale, transfer or
assignment contained in this Agreement shall again be in effect with respect to
the Transfer Stock.
2.3 Tagalong. No JWC Holder shall Transfer any shares of Subject
Securities to a Third Party (other than a Permitted Transferee) in one or a
series of related bona fide arm's-length transactions without complying with the
terms and conditions set forth in this Section 2.3; provided, however, that the
JWC Holders shall be permitted to Transfer up to 5%, in the aggregate, of the
number of shares of Subject Securities held by the Original JWC Holders as of
the date of this Agreement without compliance with this Section 2.3; provided
further, however, that this Section 2.3 shall not in any way limit or affect the
restriction contained in the last sentence of Section 2.1(a).
(a) Any JWC Holder (the "INITIATING STOCKHOLDER") desiring to
Transfer shares of Subject Securities subject to the restriction in Section 2.3
shall give not less than 10 Business Days' prior written notice of such intended
Transfer to each other Stockholder ("PARTICIPATING OFFEREES") and to the
Company. Such notice (the "PARTICIPATION NOTICE") shall set forth general terms
and conditions of such proposed Transfer, including the name of the prospective
transferee, the number of Subject Securities proposed to be transferred to the
extent known (the "PARTICIPATION SECURITIES") by the Initiating Stockholder, the
purchase price per share to the extent known proposed
13
to be paid therefor and the payment terms and type of Transfer to be
effectuated. Within 10 Business Days following the delivery of the Participation
Notice by the Initiating Stockholder to each Participating Offeree and to the
Company, each Participating Offeree shall, by notice in writing to the
Initiating Stockholder and to the Company, have the opportunity and right to
sell to the purchasers in such proposed Transfer (upon the same terms and
conditions as the Initiating Stockholder). If the Halifax Holder is a
Participating Offeree, the Halifax Holder shall have the opportunity and right
to include in such proposed Transfer an amount of Subject Securities
representing the same proportion (i.e., in relation to the aggregate amount at
the time held by the Halifax Holders) of the Subject Securities being sold by
the Initiating Stockholder (i.e., in relation to the aggregate amount at the
time held by the JWC Holders). Other Participating Offerees shall have the
opportunity and right to include in such proposed Transfer an amount of Subject
Securities up to that number of Subject Securities representing Subject
Securities at the time held by such Participating Offeree as shall equal the
product of (i) a fraction, the numerator of which is the number of Subject
Securities owned by such Participating Offeree as of the date of such proposed
Transfer and the denominator of which is the aggregate number of Subject
Securities owned as of the date of such Participation Notice by each Initiating
Stockholder and by all Participating Offerees so electing to sell Subject
Securities pursuant to this Section 2.3(a), multiplied by (ii) the number of
Subject Securities proposed to be transferred.
(b) At the closing of any proposed Transfer in respect of
which a Participation Notice has been delivered, the Initiating Stockholder,
together with all Participating Offerees so electing to sell Subject Securities
pursuant to Section 2.3(a) shall execute and deliver such documents or
instruments reasonably requested by the proposed transferee and deliver to the
proposed transferee certificates and/or other instruments representing the
Subject Securities to be sold, free and clear of all Liens, together with stock
or other appropriate powers duly endorsed therefor, and shall receive in
exchange therefor the consideration to be paid or delivered by the proposed
transferee in respect of such Subject Securities as described in the
Participation Notice.
(c) The provisions of this Section 2.3 shall not apply to (i)
any Transfer pursuant to a Public Offering or, following a Public Offering,
pursuant to a Rule 144 Transaction or (ii) any Transfers pursuant to Section 2.4
hereof.
2.4 Dragalong.
(a) If the JWC Holders (the "DRAGALONG GROUP") determine to
sell or exchange (in a sale or exchange of securities of the Company or in a
merger, consolidation or other business combination or any similar transaction)
in one or a series of related bona fide arms-length transactions to an
unaffiliated Third Party and not pursuant to a Permitted Transfer, at least 50%
of the Subject Securities (which defined term shall, for purposes of this
Section 2.4 only, include all Subject Securities regardless of vesting or
exercisability) at the time held by the JWC Holders, then upon 10 days' written
notice from the Dragalong Group to the other Stockholders, which notice shall
include reasonable details and all material terms of the proposed sale or
exchange, including the proposed time and place of closing and the form and
amount of consideration to be received by the Stockholders (such notice being
referred to as the "SALE REQUEST"), each other Stockholder shall be
14
obligated to, and shall, (i) sell, transfer and deliver, or cause to be sold,
transferred and delivered, to such Third Party the proportion of such
Stockholder's Subject Securities as is being sold by the JWC Holders in the same
transaction at the closing thereof (and shall (A) execute and deliver such
agreements for the purchase of such Subject Securities and other agreements,
instruments and certificates as the members of the Dragalong Group shall execute
and deliver in connection with such proposed transaction and (B) deliver
certificates and/or other instruments representing the proportion of such
Stockholder's Subject Securities being sold, together with stock or other
appropriate powers therefore duly executed, at the closing, free and clear of
all Liens), and each Stockholder shall receive upon the closing of such
transaction the pro rata portion (as defined below) of the consideration to be
paid or delivered by the proposed transferee in respect of such Stockholder's
Subject Securities as shall be payable to the members of the Dragalong Group in
respect of their Subject Securities (in the case of Options, warrants or other
Common Stock Equivalents, subject to subtraction of the exercise price) and (ii)
if stockholder approval of the transaction is required, vote such Stockholder's
Common Stock in favor thereof. The "PRO RATA PORTION" of each Stockholder shall
be the number of Subject Securities issued to and owned by such Stockholder
multiplied by a fraction, the numerator of which shall be the number of Subject
Securities the JWC Holders wish to Transfer, and the denominator of which shall
be the aggregate number of Subject Securities issued to or beneficially owned by
the JWC Holders participating in the sale.
(b) Each Stockholder shall be severally obligated to join on a
pro rata basis (based on such Stockholder's pro rata share of the net proceeds
paid by such Third Party) in an indemnification that is to be provided in
connection with such Sale, other than any such indemnification that relates
specifically to a particular Stockholder; provided that no Stockholder shall be
obligated in connection with such Sale to agree to indemnify or hold harmless
the Third Party with respect to an amount in excess of the net cash proceeds
paid to such Stockholder in connection with such Sale. All Stockholders will
bear their pro rata share of the costs and expenses incurred in connection with
such Sale to the extent such costs are incurred for the benefit of all
Stockholders and are not otherwise paid by the Company to the Third Party.
(c) Each Stockholder agrees that, in such Stockholder's
capacity as a stockholder of the Company, such Stockholder shall, including
pursuant to Section 2.4(a) hereof, vote, or grant proxies relating to the Common
Stock at the time held by such Stockholder to vote, all of such Stockholder's
Common Stock in favor of any sale or exchange of securities of the Company or
any merger, consolidation, recapitalization, reorganization or other business
combination or any similar transaction, including pursuant to Section 2.4(a)
hereof, if, and to the extent that, approval of the Company's stockholders is
required in order to effect such transaction.
(d) If, at the end of 90 days following the receipt by the
Stockholders of a Sale Request, the Dragalong Group has not completed the sale,
(i) each Stockholder shall be released from its obligation under the Sale
Request, (ii) the Dragalong Group shall return to each Stockholder all
certificates evidencing unsold Subject Securities and all related powers of
attorney and instruments of transfer, if any, and (iii) it shall be necessary
for a new and separate Sale Request to be furnished and the terms and provisions
of this Section 2.4 to be separately complied with in order to consummate such
sale pursuant to this Section 2.4, unless the failure to complete such sale
15
resulted from any failure by any Stockholder to comply in any material respect
with the terms of this Section 2.4.
2.5 Call by the Company.
(a) (i) If the employment of a Management Holder with the
Company and any of its Subsidiaries shall terminate (a "CALL EVENT") for any
reason, then, subject to Section 2.5(a)(ii), the Company shall have the right to
purchase (the "CALL OPTION"), by delivery of a written notice (the "CALL
NOTICE") to such terminated Management Holder (with a copy thereof to the JWC
Representative) no later than 30 days after the date of the Call Event (the
"COMPANY CALL PERIOD"), and such Management Holder and such Management Holder's
direct and indirect Permitted Transferees (a "CALL GROUP") shall be required to
sell any and all of the Subject Securities that are owned by such Call Group on
the date of the Call Event (such Subject Securities to be purchased hereunder
being referred to collectively as the "CALL SECURITIES") at, except as otherwise
provided in Section 2.5(a)(ii) hereof, a price per share equal to the greater of
(I) the Call Price of such Call Securities as of the date of the Call Event and
(II) the Cost Price of such Call Securities.
(ii) Notwithstanding anything set forth in this
Section 2.5 to the contrary, in the event a Management Holder resigns, other
than upon death or disability, without Good Reason from his employment with the
Company and its Subsidiaries, or his employment is terminated for Cause by the
Company and its Subsidiaries, then the purchase price per share payable for the
Call Securities shall be an amount equal to the Cost Price of such Call
Securities; provided, however, that if a Management Holder resigns six or more
years from the issuance of the Call Securities (or Common Stock Equivalents that
were converted or exercised into such Call Securities), then the purchase price
per share payable for the Call Securities shall equal the greater of (I) the
Call Price of such Call Securities as of the date of the Call Event and (II) the
Cost Price of such Call Securities.
(b) The closing of any purchase of Call Securities by the
Company from a Call Group pursuant to this Section 2.5 shall take place at the
principal office of the Company on such date within 15 days after the expiration
of the Company Call Period with respect to such Call Group as the Company shall
specify to the members of such Call Group in writing. At such closing, the
members of the Call Group shall deliver to the Company, against payment by the
Company of the purchase price for the Call Securities in cash (by delivery of a
certified check or checks payable to the respective members of the Call Group,
as the case may be), certificates and/or other instruments representing,
together with stock or other appropriate powers duly endorsed with respect to,
the Call Securities, free and clear of all Liens (other than pursuant to
securities laws, this Agreement or a Stock Option Agreement). All of the
foregoing deliveries will be deemed to be made simultaneously and none shall be
deemed completed until all have been completed.
(c) Notwithstanding anything set forth in this Section 2.5 to
the contrary, prior to the exercise by the Company of its Call Option to
purchase Call Securities pursuant to this Section 2.5, one or more prospective
or existing employees of the Company or any Subsidiary may be designated by the
Board of Directors (individually, a "DESIGNATED EMPLOYEE" and, collectively,
"DESIGNATED EMPLOYEES") who shall have the right, but not the obligation, to
exercise the Call
16
Option and to acquire, in lieu of the Company, some or all (as determined by the
Company) of the Call Securities that the Company is entitled to purchase from
the Call Group hereunder, for cash and otherwise on the same terms and
conditions as set forth in Section 2.5(b) which apply to the repurchase of Call
Securities by the Company. Concurrently with any such purchase of Call
Securities by any such Designated Employee, such Designated Employee shall
execute a counterpart of this Agreement whereupon such Designated Employee shall
be deemed a "Management Holder" and shall have the same rights and be bound by
the same obligations as the other Management Holders hereunder. Payment under
this Section 2.5(c) and under Section 2.5(d) below shall be made by a certified
check or checks payable to the respective members of the Call Group, in an
amount equal to the purchase price for such Call Securities under Section 2.5(a)
hereof against delivery of certificates and/or other instruments representing,
together with stock or other appropriate powers duly endorsed with respect to
such Call Securities, free and clear of all Liens (other than pursuant to
securities laws, this Agreement or a Stock Option Agreement). All of the
foregoing deliveries will be deemed to be made simultaneously and none shall be
deemed completed until all have been completed.
(d) If and to the extent neither the Company nor any
Designated Employee elects to exercise the Call Option and deliver a Call Notice
prior to the expiration of the Company Call Period with respect to such
Management Holder, then the JWC Holders and the Halifax Holders, pro rata in
accordance with the respective Common Stock Equivalents at the time held by the
JWC Holders and the Halifax Holders so exercising their rights under this
Section 2.5(d), may exercise the Call Option in lieu of the Company and such
Designated Employee by delivery of a Call Notice to such terminated Management
Holder within the Company Call Period. The closing of any purchase of Call
Securities by such JWC Holders and the Halifax Holders shall take place at the
principal offices of the Company on such date within 15 days after the
expiration of the Company Call Period with respect to such Management Holder as
the holders of a majority of the Common Stock Equivalents at the time held by
the JWC Holders and the Halifax Holders so exercising their rights under this
Section 2.5(d) shall specify to the members of such Call Group in writing,
provided that if any such JWC Holder or Halifax Holder fails to purchase all or
a portion of the number of Call Securities which such JWC Holder or Halifax
Holder may purchase pursuant to this Section 2.5(d), then the other JWC Holders
and the Halifax Holders so exercising their rights under this Section 2.5(d)
shall be entitled to purchase such Call Securities (pro rata based upon their
respective Common Stock Equivalents at the time held, or as otherwise agreed, by
such JWC Holders and the Halifax Holders).
(e) If and to the extent none of the Company, any Designated
Employees, any JWC Holders or any Halifax Holder elects to exercise the Call
Option and deliver a Call Notice within the Company Call Period or if the
closing of the purchase of all Call Securities does not occur within 15 days
after the expiration of the Company Call Period, then the Call Option provided
for in this Section 2.5 shall terminate with respect to such Subject Securities
not so purchased under this Section, but the parties hereto shall continue to be
bound by the remaining provisions of this Agreement.
17
(f) Notwithstanding the foregoing with respect to any shares
of Common Stock which, as of the date of the purchase and sale pursuant to this
Call Option, (i) were purchased as the result of the exercise of a stock option
and (ii) have not been owned by the Call Group for at least 180 days ("UNMATURED
SHARES"), the closing with respect to such Unmatured Shares shall be delayed
until a date no later than the 10th day after the 180th day following the
acquisition by the Call Group of such Unmatured Shares and the purchase price
for such Unmatured Shares will be determined at the time of such delayed
closing.
2.6 Put by the Management Holders.
(a) If a Call Event occurs by reason of a Management Holder
terminating his employment with the Company and any of its Subsidiaries for Good
Reason or his employment being terminated without Cause by the Company and any
of its Subsidiaries, then such Management Holder shall have the right to require
the Company to purchase (the "PUT OPTION"), by delivery of a written notice (the
"PUT NOTICE") to the Company during the 30-day period after the expiration of
the Company Call Period pertaining to such Management Holder (the "PUT PERIOD"),
and the Company shall be required to purchase all of the Subject Securities
described in the Put Notice (other than Subject Securities purchased under
Section 2.5) (such Subject Securities to be purchased hereunder being referred
to collectively as the "PUT SECURITIES") at a price per share equal to the Put
Price; provided that if a Management Holder exercises a Put Option within 18
months of the date hereof the Company shall be required to purchase all of the
Subject Securities described in the Put Notice at a price per share equal to the
Call Price.
(b) The closing of any purchase of Put Securities by the
Company from a Management Holder pursuant to this Section 2.6 shall take place
at the principal office of the Company on such date within 15 days after the
expiration of the Put Period with respect to such Management Holder as the
Company shall specify to such Management Holder in writing. At such closing, the
Management Holder shall deliver to the Company, against payment by the Company
of the purchase price for the Put Securities in cash (by delivery of a certified
check payable to the Management Holder) or, if the Company is required by its
senior lenders, by subordinated promissory note with a ten year maturity and
interest paid at the prime rate announced from time to time by the Company's
senior lenders (such interest payable in kind), certificates and/or other
instruments representing, together with stock or other appropriate powers duly
endorsed with respect to, the Put Securities, free and clear of all Liens (other
than pursuant to securities laws, this Agreement or a Stock Option Agreement).
All of the foregoing deliveries will be deemed to be made simultaneously and
none shall be deemed completed until all have been completed.
(c) If and to the extent a Management Holder elects not to
exercise the Put Option and deliver a Put Notice within the Put Period or if the
closing of the purchase of all Put Securities does not occur within 15 days
after the expiration of the Put Period through the fault of such Management
Holder, then the Put Option provided for in this Section 2.6 shall terminate
with respect to such Subject Securities not so purchased under this Section, but
the parties hereto shall continue to be bound by the remaining provisions of
this Agreement.
18
(d) Notwithstanding the foregoing with respect to any shares
of Common Stock which, as of the date of the purchase and sale pursuant to this
Put Option, were Unmatured Shares, the closing with respect to such Unmatured
Shares shall be delayed until a date no later than the 10th day after the 180th
day following the acquisition by the Management Holder of such Unmatured Shares
and the purchase price for such Unmatured Shares will be determined at the time
of such delayed closing.
2.7 Restrictions on Other Agreements. No Stockholder shall grant any
proxy or enter into or agree to be bound by any voting trust with respect to any
Subject Securities other than as set forth in this Agreement nor shall any
Stockholder enter into any stockholders agreements or arrangements of any kind
with any Person with respect to any of the Subject Securities on terms which
conflict with the provisions of this Agreement (whether or not such agreements
and arrangements are with other Stockholders or holders of Common Stock
Equivalents that are not parties to this Agreement), including but not limited
to, agreements or arrangements with respect to the acquisition, disposition or
voting of Subject Securities inconsistent herewith.
2.8 Transfer Subject Hereto. Except as otherwise provided in this
Agreement, in the event of an Involuntary Transfer (as defined in the following
sentence) of any Subject Securities (the "TRANSFERRED SECURITIES") of any JWC
Holder, Halifax Holder, Management Holder or Additional Holder to any Person,
the transferee, including, without limitation, any and all transferees and
subsequent transferees of the initial transferee (the "INVOLUNTARY TRANSFEREE"),
shall take and hold the Transferred Securities subject to this Agreement and to
all of the obligations of, and restrictions imposed hereby upon, the transferor
holder and shall comply with this Agreement. As used in this Agreement, the term
"Involuntary Transfer" shall mean any transaction, proceeding or action by or in
which the JWC Holder, Halifax Holder, Management Holder or Additional Holder is
involuntarily deprived or divested of any right, title or interest in or to any
of such holder's Subject Securities (including, without limitation, a seizure
under levy of attachment or execution, a foreclosure under a pledge of Subject
Securities, a transfer to a trustee in bankruptcy or receiver or other officer
or agency, or a transfer to a state or to a public officer or agency pursuant to
a statute pertaining to escheat or abandoned property but specifically excluding
death, incapacity, divorce and similar events).
2.9 Provisions in the Event of Involuntary Transfers. In the event of
an Involuntary Transfer, the Stockholders and the Company shall not take any
action to approve any such involuntary transfer not in accordance with this
Section, and the transferor Stockholder (or, if it fails to do so, the
Involuntary Transferee) shall forthwith give notice (the "INVOLUNTARY TRANSFER
NOTICE") to the Company stating (i) when the involuntary transfer occurred or is
to occur, (ii) the circumstances alleged to require such involuntary transfer,
(iii) the number and type of securities involved and (iv) the name, address and
capacity of the Involuntary Transferee.
2.10 Option. If an Involuntary Transfer of the Subject Securities of
any Stockholder occurs, the Company and its designees shall have the same rights
of first refusal with respect to the Transferred Shares as if the involuntary
transfer had been a proposed voluntary transfer by the transferor Stockholder
governed by Section 2.2 except that: (i) the periods within which such right
19
must be exercised shall run from the date the Involuntary Transfer Notice is
given in accordance with this Agreement; and (ii) such rights shall be exercised
by notice to the Involuntary Transferee rather than to the transferor
Stockholder. The closing of any purchase of Transferred Shares pursuant to this
Section shall be in accordance with the procedures set forth in Section 2.2.
2.11 (a) Purchase for Investment; Legend on Certificate. Each
Stockholder acknowledges that all of the securities of the Company held by such
Stockholder are being (or have been) acquired for investment and not with a view
to the distribution thereof and that no Transfer, hypothecation or assignment of
any such securities (including the Common Stock for which such securities may be
exercisable or exchangeable or into which such securities may be convertible)
may be made except in compliance with applicable federal and state securities
laws. All the certificates or other instruments representing any of such
securities (including the Common Stock for which such securities may be
exercisable or exchangeable or into which such securities may be convertible)
which are now or hereafter held by any Stockholder shall be subject to the terms
of this Agreement and shall have endorsed in writing, stamped or printed,
thereon the following legends:
"THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE
TERMS AND CONDITIONS OF AN AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
DATED AS OF OCTOBER 17, 2001, AS AMENDED FROM TIME TO TIME, A COPY OF
WHICH IS ON FILE WITH AND AVAILABLE FROM THE SECRETARY OF THE COMPANY."
"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE
STATE SECURITIES LAWS AND MAY NOT BE SOLD, ASSIGNED, TRANSFERRED,
PLEDGED OR OTHERWISE DISPOSED OF EXCEPT IN COMPLIANCE WITH THE
REQUIREMENTS OF SUCH ACT."
(b) Removal of Legends, Etc. Notwithstanding the provisions of
Section 2.11(a) upon the transferability of any Subject Securities, the
restrictions thereunder shall cease and terminate when (i) such Subject
Securities are sold or otherwise disposed of in accordance with the intended
method of disposition by the seller or sellers thereof set forth in a
registration statement or are sold or otherwise disposed of in a transaction
which does not require that the securities transferred bear the legend set forth
in Section 2.11 or (ii) the holder of such Subject Securities has met the
requirement of transfer of such Subject Securities pursuant to subparagraph (k)
of Rule 144. Whenever the restrictions imposed by Section 2.11(a) shall
terminate, as herein provided, the holder of any Subject Securities shall be
entitled to receive from the Company, without expense, a new certificate not
bearing the restrictive legend set forth in Section 2.11(a) and not containing
any other reference to the restrictions imposed by Section 2.11(a).
2.12 Effectiveness of Transfers. Any Subject Securities transferred by
a Stockholder (other than pursuant to an effective registration statement under
the Securities Act or a Rule 144 Transaction if the Subject Securities are
listed or admitted to trading on an Active Trading Market) shall be held by the
transferee thereof pursuant to this Agreement. Such transferee shall, except as
20
otherwise expressly stated herein, have all the rights and be subject to all of
the obligations of a Stockholder under this Agreement automatically and without
requiring any further act by such transferee or by any parties to this
Agreement. Without affecting the preceding sentence, if such transferee is not a
Stockholder on the dates of such transfer, then such transferee, as a condition
to such transfer, shall confirm such transferee's obligations hereunder in
accordance with Section 2.13 hereof. No Subject Securities shall be transferred
on the Company's books and records, and no transfer thereof shall be otherwise
effective, unless any such transfer is made in accordance with the terms and
conditions of this Agreement, and the Company is hereby authorized by all of the
Stockholders to enter appropriate stop transfer notations on its transfer
records to give effect to this Agreement.
2.13 Additional Stockholders. Any Person that is not already a party to
this Agreement in the same Stockholder capacity as such Person would be
following the Transfer and who is acquiring any Subject Securities (except for
any acquisition thereof (a) in an offering registered under the Securities Act
or (b) in a Rule 144 Transaction if the Subject Securities are listed or
admitted to trading on an Active Trading Market) shall on or before the transfer
or issuance to it of such Subject Securities, sign and deliver to the Company a
Joinder Agreement and shall thereby become a party to this Agreement. If such
Person meets the definition of a JWC Holder, then such Person shall be treated
as a JWC Holder hereunder, if such Person meets the definition of a Halifax
Holder, such Person shall be treated as a Halifax Holder hereunder, if such
Person meets the definition of a Management Holder, such Person shall be treated
as a Management Holder hereunder, and if such Person meets none of the foregoing
definitions, such Person shall be treated as an Additional Holder hereunder. The
Company shall require each Person acquiring an option, warrant or other right to
purchase shares of Common Stock under any option or other equity participation
plan to execute a Joinder Agreement.
2.14 Notice of Transfer. Each JWC Holder, Halifax Holder, Management
Holder or Additional Holder agrees, prior to any Transfer of any Subject
Securities (except pursuant to an effective registration statement), to give
written notice to the Company of such holder's intent to effect such Transfer
and agrees to comply in all other respects with the provisions of this
Agreement. Each such notice shall describe the manner and circumstances of the
proposed Transfer and, unless the proposed Transfer is a Permitted Transfer or
unless waived by the Company, shall be accompanied by the written opinion,
addressed to the Company, of counsel for the holder of such Subject Securities
(which counsel shall be reasonably satisfactory to the Company), stating that in
the opinion of such counsel (which opinion shall be reasonably satisfactory to
the Company) such proposed Transfer does not involve a transaction requiring
registration or qualification of such Subject Securities under the Securities
Act or the securities laws of any state of the United States or of any foreign
jurisdiction. Subject to complying with the other applicable provisions of this
Agreement, such holder of Subject Securities shall be entitled to consummate
such Transfer in accordance with the terms of the notice delivered by it to the
Company if the Company does not object (on the basis that such Transfer violates
this Section 2.14) to such Transfer within 5 Business Days after the delivery of
such notice.
21
ARTICLE III
Registration Rights
3.1 General. For purposes of this Article III, (a) the terms
"REGISTER", "REGISTERED" and "REGISTRATION" refer to a registration effected by
preparing and filing a registration statement on Form X-0, X-0 or S-3 in
compliance with the Securities Act and the declaration or ordering of
effectiveness of such registration statement and (b) the term "HOLDER" means any
Stockholder electing to register any Registrable Securities pursuant to Section
3.2 or 3.3. The registration rights granted pursuant to Sections 3.2 and 3.3
shall terminate and expire on the fourth anniversary of the occurrence of a
Public Offering.
3.2 Required Registration. If the Company shall be requested, in
writing, by the holders of a majority of the Common Stock Equivalents then held
by the JWC Holders (or the JWC Representative) to effect a registration
statement under the Securities Act of Registrable Securities, the Company shall
promptly (i) give written notice of the proposed registration to all other
Stockholders and (ii) use its best efforts to effect the registration under the
Securities Act of the Registrable Securities which the Company has been so
requested to register by the JWC Holders and by other Stockholders in a written
request received by the Company within 10 Business Days after the giving of the
written notice specified in clause (i) above; provided, however, that the
Company shall not be obligated to effect any registration under the Securities
Act except in accordance with the following provisions:
(a) The Company shall not be obligated to use its best efforts
to file and cause to become effective any registration statement during any
period in which any other registration statement (other than on Forms S-4, F-4
or S-8 promulgated under the Securities Act or any successor forms thereto)
pursuant to which Primary Shares are to be or were sold has been filed and not
withdrawn or has been declared effective within the prior 90 days.
(b) The Company may delay the filing or effectiveness of any
registration statement for a period of up to 90 days after the date of a request
for registration pursuant to this Section 3.2 if at the time of such request (i)
the Company is engaged, or has fixed plans to engage within 90 days after the
date of such request, in a firm commitment underwritten public offering of
Primary Shares in which the holders of Registrable Securities may include
Registrable Securities pursuant to Section 3.3 or (ii) a Material Transaction
exists, provided that the Company may only so delay the filing or effectiveness
of its registration statements (if any) once pursuant to this Section 3.2(b).
(c) With respect to any registration pursuant to this Section
3.2, the Company may include in such registration any Primary Shares; provided,
however, that, if the managing underwriter advises the Company that the
inclusion of all Registrable Securities and Primary Shares proposed to be
included in such registration would interfere with the successful marketing
(including pricing) of the Registrable Securities proposed to be included in
such registration, then the number
22
of Registrable Securities and Primary Shares proposed to be included in such
registration shall be included in the following order:
(i) first, the Registrable Securities requested to be
included in such registration (or, if necessary, such Registrable Securities pro
rata among the Holders of such Registrable Securities based upon the number of
Registrable Securities requested to be included in such registration); and
(ii) second, the Primary Shares.
(d) If the method of disposition requested by the holders
pursuant to this Section 3.2 is an underwritten public offering, Stockholders
holding a majority of the Registrable Securities requested to be registered
shall have the right to designate the managing underwriter of such offering,
subject to the consent of the Company, which consent shall not be unreasonably
withheld.
(e) At any time before the registration statement covering
Registrable Securities becomes effective, the Stockholders holding a majority of
the Registrable Securities requested to be registered may request the Company to
withdraw or not to file the registration statement.
3.3 Piggyback Registration.
(a) If, at any time, the Company determines to register any
Common Stock under the Securities Act in connection with a Public Offering of
such securities, the Company shall, at each such time, promptly give each
Stockholder written notice of such determination no later than 30 days before
its intended filing with the SEC. Upon the written request of any Stockholder
received by the Company within 10 Business Days after the giving of any such
notice by the Company, the Company shall use its best efforts to cause to be
registered under the Securities Act all of the Registrable Securities of such
Stockholder that such Holder has requested be registered for disposition in
accordance with the Company's intended method of disposition as stated in such
notice and with the underwriter selected by the Company. If the total amount of
Registrable Securities that are to be included by the Company in such
registration exceeds the amount of securities that the managing underwriters
reasonably believe can be sold in an orderly manner in such offering within a
price range acceptable to the Company, then the Company will include in such
registration only the number of securities which in the opinion of such
underwriters can be sold in the manner described above, in the following order:
(i) first, all securities of the Company to be
offered for the account of the Company; and
(ii) second, the Registrable Securities requested to
be included in such registration, (or if necessary, such Registrable
Securities pro rata among the Holders of such securities based on the
number of Registrable Securities requested to be included in such
registration).
23
Notwithstanding the foregoing, the Company shall not be obligated to include in
an initial Public Offering any Registrable Securities of any Holder if the JWC
Holders do not elect to include their Registrable Securities in such a
registration. If any of the Holders disapproves of the terms of any such
underwriting, it may elect to withdraw therefrom by written notice to the
Company and the underwriter prior to the date of pricing such offer. Any
Registrable Securities or other securities excluded or withdrawn from such
underwriting shall be withdrawn from such registration.
3.4 Obligations of the Company.
(a) Whenever required under Section 3.2 or 3.3 to use its best
efforts to effect the registration of any Registrable Securities, the Company
shall (provided, that the Company may at any time delay or abandon the
underlying registration without any liability to the Holders):
(i) prepare and file with the SEC a registration
statement (or an amendment to a registration statement) with respect to
such Registrable Securities and use its best efforts to cause such
registration statement to become and remain effective, including,
without limitation, filing of post-effective amendments and supplements
to any registration statement or prospectus necessary to keep the
registration statement current;
(ii) as expeditiously as reasonably possible, prepare
and file with the SEC such amendments and supplements to such
registration statement and the prospectus used in connection with such
registration statement as may be necessary to comply with the
provisions of the Securities Act with respect to the disposition of all
securities covered by such registration statement and to keep each
registration and qualification under this Agreement effective (and in
compliance with the Securities Act) by such actions as may be necessary
or appropriate for a period of 120 days after the effective date of
such registration statement (unless all securities covered by such
registration statement are sooner disposed of), all as requested by
such Holder or Holders;
(iii) as expeditiously as reasonably possible furnish
to the Holders such numbers of copies of a prospectus, including a
preliminary prospectus, in conformity with the requirements of the
Securities Act, and such other documents as they may reasonably request
in order to facilitate the disposition of Registrable Securities owned
by them in accordance with the plan of distribution provided for in
such registration statement;
(iv) as expeditiously as reasonably possible use its
best efforts to register and qualify the securities covered by such
registration statement under such securities or "blue sky" laws of such
jurisdictions as shall be reasonably appropriate for the distribution
of the securities covered by the registration statement, provided that
the Company shall not be required in connection therewith or as a
condition thereto to qualify to do business in any jurisdiction it
would not otherwise be required to qualify but for this subsection
(iv), to file a general consent to service of process in any such
jurisdiction or subject itself to taxation in any such jurisdiction,
and further provided that (anything in this Agreement to the contrary
24
notwithstanding with respect to the bearing of expenses) if any
jurisdiction in which the securities shall be qualified shall require
by law or regulation that expenses incurred in connection with the
qualification of the securities in that jurisdiction be borne by
selling stockholders, then such expenses shall be payable by selling
stockholders pro rata, to the extent required by such jurisdiction;
(v) notify each Holder of Registrable Securities
covered by such registration statement, at any time when a prospectus
relating thereto is required to be delivered under the Securities Act,
upon discovery that, or upon the happening of any event as a result of
which, the prospectus included in such registration statement, as then
in effect, includes an untrue statement of a material fact or omits to
state any material fact required to be stated therein or necessary to
make the statements therein not misleading in the light of the
circumstances under which they were made (provided that upon such
notification, each Holder agrees not to sell or otherwise transfer or
dispose of any Common Stock (or other securities) of the Company at the
time held by such Holder or any interest or future interest therein
until such statement or omission has been corrected, and there shall be
added to the period during which the Company is obligated to keep such
registration effective the number of days for which such sales or other
transfers or dispositions were suspended), and at the request of any
such Holder promptly prepare and furnish, without charge, to such
seller or Holder a reasonable number of copies of a supplement to such
prospectus or an amendment of such registration statement as may be
necessary so that, as thereafter delivered to the purchasers of such
securities, such prospectus shall not include an untrue statement of a
material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading in
the light of the circumstances under which they were made;
(vi) otherwise use its best efforts to comply with
all applicable rules and regulations of the SEC, and make available to
its security holders, as soon as reasonably practicable, an earnings
statement covering the period of at least 12 months but not more than
18 months, beginning with the first full calendar month after the
effective date of such registration statement, which earnings statement
shall satisfy the provisions of Section 11(a) of the Securities Act or
Rule 158 thereunder; and
(vii) use its best efforts to list all Registrable
Securities covered by such registration statement on any securities
exchange on which any class of similar Securities is then listed.
(b) If the Company at any time proposes to register any of its
securities under the Securities Act subject to the registration rights of the
Holders under Section 3.2 or 3.3, and such securities are to be distributed by
or through one or more underwriters selected by the Company, then the Company
will make reasonable efforts, if requested by any Holder of Registrable
Securities who requests such registration, to arrange for such underwriters to
include such Registrable Securities among the securities to be distributed by or
through such underwriters.
25
(c) In connection with the preparation and filing of each
registration statement registering Registrable Securities under this Agreement,
the Company will give the Holders of Registrable Securities on whose behalf such
Registrable Securities are to be so registered and their underwriters, if any,
and their respective counsel and accountants the opportunity to participate in
the preparation of such registration statement, each prospectus included therein
or filed with the SEC, and each amendment thereof or supplement thereto, and
will give each of them such access to its books and records and such
opportunities to discuss the business of the Company with its officers, its
counsel and the independent public accountants who have certified its financial
statements, as shall be reasonably necessary, in the opinion of such Holders or
such underwriters or their respective counsel, in order to conduct a reasonable
and diligent investigation within the meaning of the Securities Act.
3.5 Furnish Information. It shall be a condition precedent to the
obligations of the Company to take any action pursuant to this Article III that
each Holder shall furnish to the Company such information regarding such Holder,
the Registrable Securities held by such Holder, and the intended method of
disposition of such securities as the Company shall reasonably request and as
shall be required in connection with the action to be taken by the Company.
3.6 Expenses of Registration. Registration, filing and qualification
fees, printers' and accounting fees, fees and expenses of compliance with
securities or blue sky laws, fees and expenses relating to filings with the
National Association of Securities Dealers, Inc. or any applicable securities
exchange, fees of underwriters (excluding discounts, commissions or fees of
underwriters, selling brokers, dealer managers or similar securities industry
professionals attributable to the Registrable Securities being registered), and
fees and disbursements of counsel for the Company incurred in connection with a
registration pursuant to Section 3.2 or 3.3 shall be borne by the Company. Each
Holder whose shares are being sold will bear, pro rata, underwriters' discounts
and brokerage and other commissions, fees and disbursements of its own counsel
and all of its other expenses of such registration, offering and sale.
3.7 Underwriting Requirements. In connection with any registration of
Registrable Securities under this Agreement, the Holders whose shares are being
sold shall, if requested by the Company or the underwriters, enter into an
underwriting agreement with such underwriters for such offering, such agreement
to contain such terms and provisions as are customarily contained in
underwriting agreements with respect to secondary distributions, including,
without limitation, provisions relating to indemnification and contribution. The
Holders on whose behalf Registrable Securities are to be distributed shall also
complete and execute all questionnaires, powers of attorney and/or other
documents required under the terms of such underwriting agreement.
3.8 Indemnification. In the event any Registrable Securities are
included in a registration statement pursuant to this Article III:
(a) To the fullest extent permitted by law, the Company will
indemnify and hold harmless each Holder joining in a registration and its
directors and officers, any underwriter (as defined in the Securities Act) for
it, and each Person, if any, who controls such Holder or such
26
underwriter within the meaning of the Securities Act, from and against any
losses, claims, damages, expenses (including reasonable attorneys' fees and
expenses and reasonable costs of investigation) or liabilities, joint or
several, to which they or any of them may become subject under the Securities
Act or otherwise, insofar as such losses, claims, damages, expenses or
liabilities (or actions or proceedings, whether commenced or threatened, in
respect thereof) arise out of or are based on any untrue or alleged untrue
statement of any material fact contained in such registration statement
including any preliminary prospectus or final prospectus contained therein or
any amendments or supplements thereto, or arise out of or are based upon the
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements made therein not misleading
in light of the circumstances under which they were made, provided that the
indemnity agreement contained in this Section 3.8(a) shall not apply to amounts
paid in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of the Company (which consent shall
not be unreasonably withheld), nor shall the Company be liable for any such
loss, claim, damage, liability or action to the extent that it arises out of or
is based upon (i) an untrue statement or omission made in connection with such
registration statement, preliminary prospectus, final prospectus or amendments
or supplements thereto in reliance upon and in conformity with written
information furnished by such Holder, underwriter or control person to the
Company specifically for inclusion in the Registration Statement in connection
with such registration, or (ii) such Holder's failure to deliver a copy of the
registration statement or prospectus or any amendments or supplements thereto
after the Company has furnished such Holder with a sufficient number of copies
of the same. Such indemnity shall remain in full force and effect regardless of
any investigation made by or on behalf of such Holder, underwriter or control
person and shall survive the transfer of such securities by such Holder.
(b) To the fullest extent permitted by law, each Holder
joining in a registration shall indemnify and hold harmless the Company, each of
its directors, each of its officers who has signed the registration statement,
each Person, if any, who controls the Company within the meaning of the
Securities Act, and each agent and any underwriter for the Company and any
Person who controls any such agent or underwriter and each other Holder and any
Person who controls such Holder (within the meaning of the Securities Act)
against any losses, claims, damages, expenses (including reasonable attorney's
fees and expenses and reasonable costs of investigation) or liabilities to which
the Company or any such director, officer, control person, agent, underwriter or
other Holder may become subject, under the Securities Act or otherwise, insofar
as such losses, claims, damages or liabilities (or actions or proceedings,
whether commenced or threatened, in respect thereof) arise out of or are based
upon an untrue statement of any material fact contained in such registration
statement, including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto, or arise out of or are based
upon the omission to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading, in each case to the
extent that such untrue statement or omission was made in such registration
statement, preliminary or final prospectus, or amendments or supplements
thereto, in reliance upon and in conformity with written information furnished
by such Holder in connection with such registration, provided that the indemnity
agreement contained in this Section 3.8(b) shall not apply to amounts paid in
settlements effected without the consent of such Holder (which consent shall not
be unreasonably withheld). Such indemnity shall remain in full force and effect
regardless
27
of any investigation made by or on behalf of the Company or any such director,
officer, Holder, underwriter or control person and shall survive the transfer of
such securities by such Holder.
(c) Any Person seeking indemnification under this Section 3.8
will (i) give prompt written notice to the indemnifying party of any claim with
respect to which it seeks indemnification, but the failure to give such notice
will not affect the right to indemnification hereunder, except to the extent the
indemnifying party is actually prejudiced by such failure and (ii) unless in
such indemnified party's reasonable judgment a conflict of interest may exist
between such indemnified and indemnifying parties with respect to such claim,
permit such indemnifying party, and other indemnifying parties similarly
situated, jointly to assume the defense of such claim with counsel reasonably
satisfactory to the parties. In the event that the indemnifying parties cannot
mutually agree as to the selection of counsel, each indemnifying party may
retain separate counsel to act on its behalf and at its expense. The indemnified
party shall in all events be entitled to participate in such defense at its
expense through its own counsel. If such defense is not assumed by the
indemnifying party, the indemnifying party will not be subject to any liability
for any settlement made without its consent (but such consent will not be
unreasonably withheld). No indemnifying party will consent to entry of any
judgment or enter into any settlement which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such indemnified party
of a release from all liability in respect of such claim or litigation. An
indemnifying party who is not entitled to, or elects not to, assume the defense
of a claim will not be obligated to pay the fees and expenses of more than one
counsel for all parties indemnified by such indemnifying party with respect to
such claim.
(d) If for any reason the foregoing indemnification is
unavailable to any party or insufficient to hold it harmless as and to the
extent contemplated by the preceding paragraphs of this Section 3.8, then each
indemnifying party shall contribute to the amount paid or payable by the
indemnified party as a result of such loss, claim, damage expense or liability
in such proportion as is appropriate to reflect the relative benefits received
by the indemnifying party, on the one hand, and the applicable indemnified
party, as the case may be, on the other hand, and also the relative fault of the
indemnifying party and any applicable indemnified party, as the case may be, as
well as any other relevant equitable considerations. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person or entity who
was not guilty of such fraudulent misrepresentation.
3.9 Market Stand-Off Agreement. If requested by the managing
underwriter of the initial Public Offering on behalf of the Company of its
Common Stock, or by the managing underwriter of a Public Offering for which
Registrable Securities of any Holders have been registered, all Holders (in the
case of such initial Public Offering) or such participating Holders (in the case
of such other Public Offering) shall not sell or otherwise transfer or dispose
of any Registrable Securities held by such Holders (other than pursuant to
Permitted Transfers, pursuant to Section 2.3 and other than those Registrable
Securities included in the registration) during such period following the
effective date of such registration as is usual and customary at such time in
similar public offerings of similar securities.
28
ARTICLE IV
Corporate Governance
4.1 Board of Directors.
(a) The Company and each of the Stockholders shall take all
action, including, but not limited to, such Stockholder's voting, or executing
proxies or written consents with respect to, the Voting Stock at the time held
by such Stockholder as may be from time to time requested by holders of a
majority of the Common Stock Equivalents at the time held by the JWC Holders (or
the JWC Representative) so that the Board of Directors shall consist of such
number of directors, no less than seven and up to a maximum of ten directors, as
may be from time to time designated by the holders of a majority of the Common
Stock Equivalents at the time held by the JWC Holders (or the JWC
Representative).
(b) The Company and each of the Stockholders shall take all
action, including, but not limited to, such Stockholder's voting, or executing
proxies or written consents with respect to, the Voting Stock at the time held
by such Stockholder as may be from time to time requested by holders of a
majority of the Common Stock Equivalents at the time held by the JWC Holders (or
the JWC Representative) so that the Board of Directors shall include such
directors as may be from time to time designated by the holders of a majority of
the Common Stock Equivalents at the time held by the JWC Holders (or the JWC
Representative). The holders of a majority of the Common Stock Equivalents at
the time held by the JWC Holders (or the JWC Representative) shall also be
entitled to require that any member of the Board of Directors so designated
pursuant to this Section 4.1(b) be removed or replaced by another designee of
the holders of a majority of the Common Stock Equivalents at the time held by
the JWC Holders (or the JWC Representative), in which event the Company and each
Stockholder shall take all action, including, but not limited to, such
Stockholder's voting, or executing proxies or written consents with respect to,
the Voting Stock at the time held by such Stockholder as may be necessary to
effect such removal or replacement.
(c) Notwithstanding the provisions of Section 4.1(b), the
Company and each Stockholder shall take all action, including, but not limited
to, such Stockholder's voting, or executing proxies or written consents with
respect to, the Voting Stock at the time held by such Stockholder as may be from
time to time requested by the holders of a majority of the Common Stock
Equivalents at the time held by the Original Halifax Holders and their Permitted
Transferees (other than the JWC Holders and Management Holders) or on their
behalf by the Halifax Representative, so that the Board of Directors shall
include two directors designated by the holders of a majority of the Common
Stock Equivalents held by the Original Halifax Holders and their Permitted
Transferees (other than the JWC Holders and Management Holders) or on their
behalf by the Halifax Representative which directors (the "Halifax Directors")
shall initially be Xxxxx Xxxxxx and Xxxxxxx Xxxxx; provided that the number of
Halifax Directors that the Original Halifax Holders and their Permitted
Transferees (other than the JWC Holders and Management Holders) shall be
entitled to designate pursuant to this Section 4.1(c) shall be permanently
reduced from two to one director at such time as the Original Halifax Holders
and their Permitted Transferees (other than the
29
JWC Holders and Management Holders) hold less than 50% of the Common Stock
Equivalents held by the Original Halifax Holders as of the date of this
Agreement; provided further, that the number of Halifax Directors designated
pursuant to this Section 4.1(c) shall be permanently reduced to zero directors
at such time as the Original Halifax Holders and their Permitted Transferees
(other than the JWC Holders and Management Holders) hold less than 5% of the
Common Stock Equivalents outstanding. The holders of a majority of the Common
Stock Equivalents at the time held by the Original Halifax Holders and their
Permitted Transferees (other than the JWC Holders and Management Holders) or on
their behalf by the Halifax Representative shall also be entitled to require
that any director so designated pursuant to this Section 4.1(c) be removed or
replaced by another designee of the holders of the majority of the Common Stock
Equivalents at the time held by the Original Halifax Holders and their Permitted
Transferees (other than the JWC Holders and Management Holders) or on their
behalf by the Halifax Representative, in which event the Company and each
Stockholder shall take all action, including, but not limited to, such
Stockholder's voting, or executing proxies or written consents with respect to,
the Voting Stock at the time held by such Stockholder as may be necessary to
effect such removal or replacement.
4.2 Rights of the Halifax Directors.
(a) Notwithstanding that no vote may be required, or that a
lesser percentage vote may be specified in the certificate of incorporation or
by-laws of the Company, the Company shall not take, and no Stockholder shall
cause the Company to take, any of the following actions without the affirmative
vote of a majority of the Board of Directors, which majority vote shall include
the affirmative vote of the directors, if any, designated pursuant to Section
4.1(c) (the "HALIFAX AFFIRMATIVE BOARD VOTE"):
(i) the redemption, purchase or other acquisition of
any Common Stock Equivalents other than those redemptions, purchases or
acquisitions made (A) pursuant to this Agreement, (B) on a pro rata basis among
the holders of a particular class or series of securities of the Company or (C)
pursuant to the terms of securities of the Company created after the date hereof
which require such redemption, purchase or acquisition;
(ii) the declaration or payment of any dividend or
other distribution by the Company with respect to any Common Stock Equivalents
other than those declarations or payments of dividends or other distributions
that are made (A) on pro rata basis among the holders of a particular class or
series of securities of the Company or (B) pursuant to the terms of securities
of the Company created after the date hereof which require such declaration,
payment or other distribution;
(iii) the termination of the Chief Executive Officer
of the Company without Cause (as defined in such individual's then current
employment agreement with the Company or one of its subsidiaries);
(iv) any issuance of Common Stock Equivalents in
connection with a transaction or series of related transactions involving an
acquisition of the equity or assets of a Third
30
Party which results in an aggregate issuance of greater than 20% of the total
outstanding Common Stock Equivalents,
(v) the entering into of any transaction or
agreement, directly or indirectly, by the Company with JWC Inc. or any director,
officer or Affiliate of JWC Inc., including any of the portfolio companies held
or managed by any such entity (which affirmative vote of the Halifax Directors
shall not be unreasonably withheld); or
(vi) any significant change in the nature of the
Company's business as of the date hereof.
Notwithstanding anything to the contrary herein, (x) the Halifax Affirmative
Board Vote shall no longer be necessary with respect to the matters set forth in
clauses (iii) and (iv) above at such time as the Original Halifax Holders and
their Permitted Transferees (other than the JWC Holders and Management Holders)
hold less than 50% of the Common Stock Equivalents held by the Original Halifax
Holders as of the date of this Agreement and (y) the provisions of this Section
4.2 shall terminate at such time as the Original Halifax Holders and their
Permitted Transferees (other than the JWC Holders and Management Holders) hold
less than 5% of the Common Stock Equivalents.
(b) As long as at least one Halifax Director is a member of
the Board of Directors pursuant to Section 4.1(c), there shall be at least one
Halifax Director on each committee, if any, established by the Board of
Directors.
4.3 Rights Non-Transferable. Notwithstanding anything to the contrary
herein, the rights of the Original Halifax Holders and their Permitted
Transferees (other than the JWC Holders and Management Holders) and the Halifax
Directors under Section 4.1 and 4.2, respectively, may only be exercised by the
Original Halifax Holders and their Permitted Transferees (other than the JWC
Holders and Management Holders) and Halifax Directors, respectively, and may not
be transferred or assigned in connection with any other Transfer of Subject
Securities or otherwise.
ARTICLE V
Preemptive Rights
5.1 Rights to Subscribe for Securities.
(a) Except in the case of Excluded Securities (as defined in
Section 5.1(e)), the Company shall not, and shall cause its Subsidiaries not to,
issue or sell any Common Stock Equivalent, unless the Company shall have first
offered or caused such Subsidiary to offer (the "PREEMPTIVE OFFER") to sell such
Common Stock Equivalents to the JWC Holders and Halifax Holders (the "OFFERED
SECURITIES") by delivery to such JWC Holders and Halifax Holders of written
notice of such offer stating that the Company or such Subsidiary proposes to
sell such Offered Securities, the number or amount of the Offered Securities
proposed to be sold, the proposed purchase price therefor and any other terms
and conditions of such offer. The Preemptive Offer shall
31
by its terms remain open and irrevocable for a period of 10 Business Days from
the date it is received from the Company (the "PREEMPTIVE OFFER PERIOD").
(b) Each JWC Holder and Halifax Holder shall have the option,
exercisable at any time during the Preemptive Offer Period by delivering written
notice to the Company or such Subsidiary (a "PREEMPTIVE OFFER ACCEPTANCE
NOTICE"), to subscribe for the number or amount of such Offered Securities that
would permit such JWC Holders and Halifax Holders to maintain its Offeree
Percentage as it existed immediately prior to such issuance, sale or exchange.
The Company or such Subsidiary shall notify each JWC Holder and Halifax Holder
within five days following the expiration of the Preemptive Offer Period of the
number or amount of Offered Securities which such JWC Holder and Halifax Holder
has subscribed to purchase.
(c) If Preemptive Offer Acceptance Notices are not given by
the JWC Holders and Halifax Holders for all of the Offered Securities, the
Company or such Subsidiary making such Preemptive Offer shall have 60 days from
the expiration of the Preemptive Offer Period to sell all or any part of such
Offered Securities as to which Preemptive Offer Acceptances Notices have not
been given by the JWC Holders and Halifax Holders (the "REFUSED SECURITIES") to
any other Persons upon the terms and conditions including price, which are no
more favorable, in the aggregate, to such other Persons or less favorable to the
Company or such Subsidiary than those set forth in the Preemptive Offer.
(d) Upon the closing, which shall include full payment to the
Company or such Subsidiary, of the sale to such other Persons of all the Refused
Securities, such JWC Holders and Halifax Holders shall purchase from the Company
or such Subsidiary, and the Company or such Subsidiary shall sell to such JWC
Holders and Halifax Holders, the Offered Securities with respect to which
Preemptive Offer Acceptance Notices were delivered by such JWC Holders and
Halifax Holders, at the terms specified in the Preemptive Offer.
(e) The rights of the JWC Holders and Halifax Holders under
this Section 5.1 shall not apply to the following securities (the "EXCLUDED
SECURITIES"):
(i) any Common Stock Equivalents issued or granted
pursuant to a stock option or other similar equity incentive plan providing for
issuance to employees or consultants of the Company or its Subsidiaries or upon
the exercise or conversion of options or other Common Stock Equivalents issued
to employees and consultants of the Company or its Subsidiaries;
(ii) any Common Stock Equivalents and other
derivative securities issued upon the exercise or conversion of outstanding
Common Stock Equivalents;
(iii) any Common Stock Equivalents issued to any
individual or entity which, in connection with the issuance of Common Stock
Equivalents to such entity, simultaneously enters into a significant business
transaction with the Company which is directly related to the Company's
business;
32
(iv) any Common Stock Equivalents issued as part of a
Public Offering or any effective registration statement under the Securities
Act; and
(v) any Common Stock Equivalents issued to the
Company or a Subsidiary.
ARTICLE VI
Certain Miscellaneous Other Provisions
6.1 Remedies. Each of the parties hereto acknowledges and agrees that
no remedy at law would be adequate in the event of any breach of this Agreement.
Accordingly, if any dispute arises concerning the sale or other disposition of
any of the securities of the Company subject to this Agreement or concerning any
other provisions hereof or the obligations of the parties hereunder, each party
hereto agrees that, in addition to any other remedy to which they may be
entitled at law or in equity, the other parties hereto shall be entitled to a
decree of specific performance to enforce this Agreement (without bond or other
security being required unless the party seeking such remedy fails to
demonstrate to an appropriate court having jurisdiction that such party has a
likelihood of success on the merits), and each party hereto waives the defense
in any action or proceeding brought to enforce this Agreement that there exists
an adequate remedy at law. Such remedies shall be cumulative and non-exclusive
and shall be in addition to any other rights and remedies the parties may have
under this Agreement or otherwise.
6.2 Entire Agreement; Amendment; Termination.
(a) This Agreement sets forth the entire understanding of the
parties, and supersedes all prior agreements and all other arrangements and
communications, whether oral or written, with respect to the subject matter
hereof.
(b) The Schedule of Stockholders may be amended in writing by
the Company to reflect changes in the composition of the Stockholders and
changes in their addresses or telecopy numbers that may occur from time to time
as a result of Permitted Transfers, Transfers permitted under Article II hereof
or any new issuance by the Company of Common Stock or Common Stock Equivalents;
provided, however, that no new issuance of Common Stock or Common Stock
Equivalents shall be effective unless and until the Person receiving such
securities (if not already a party hereto in such capacity) executes and
delivers to the Company an executed Joinder Agreement in accordance with Section
2.13 hereof. Amendments to the Schedule of Stockholders reflecting Permitted
Transfers or Transfers permitted under Article II hereof shall become effective
when the amended Schedule of Stockholders, and a copy of a Joinder Agreement as
executed by any new transferee in accordance with Section 2.13, are filed with
the Company.
33
(c) Any other amendment to this Agreement shall be in writing
and shall require the written consent of (a) the Company, (b) either the JWC
Representative or the holders of a majority of Common Stock Equivalents at the
time held by the JWC Holders, and, (c) if adverse to the interests of a
particular Stockholder or Stockholder Group, then the consent of each particular
Stockholder or the holders of a majority of the Common Stock Equivalents at the
time held by such particular Stockholder Group, as the case may be, to whose
interest such amendment is adverse.
(d) Notwithstanding the foregoing provisions of this Section
6.2, this Agreement may be terminated at any time upon the written consent of
(i) the Company and (ii) the holders of a majority of the Common Stock
Equivalents at the time held by the Management Holders and (iii) the holders of
a majority of the Common Stock Equivalents at the time held by the Halifax
Holders and (iv) the holders of a majority of the Common Stock Equivalents at
the time held by the JWC Holders (or the JWC Representative), each voting
separately as a group.
6.3 Severability. Any term or provision of this Agreement that is
invalid or unenforceable in any situation in any jurisdiction shall not affect
the validity or enforceability of the remaining terms and provisions hereof or
the validity or enforceability of the offending term or provision in any other
situation or in any other jurisdiction. If the final judgment of a court of
competent jurisdiction declares that any term or provision hereof is invalid or
unenforceable, the parties agree that the body making the determination of
invalidity or unenforceability shall have the power to reduce the scope,
duration or area of the term or provision, to delete specific words or phrases,
or to replace any invalid or unenforceable term or provision with a term or
provision that is valid and enforceable and that comes closest to expressing the
intention of the invalid or unenforceable term or provision, and this Agreement
shall be enforceable as so modified after the expiration of the time within
which the judgment may be appealed.
6.4 Notices. All notices, consents and other communications required,
or contemplated under this Agreement shall be in writing and shall be delivered
in the manner specified herein or, in the absence of such specification, shall
be deemed to have been duly given (i) 3 Business Days after mailing by first
class certified mail, postage prepaid, (ii) when delivered by hand, (iii) upon
confirmation of receipt by telecopy, or (iv) 1 day after sending by overnight
delivery service, to the respective addresses or telecopy numbers of the parties
set forth below:
(a) For notices and communications to the Company:
c/o X.X. Childs Associates, L.P.
000 Xxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxxxxx, XX 00000
Attention: Xxxxxx X. Xxx
Telecopy: 617-753-1101
and
34
InSight Health Services Holdings Corp.
c/o X.X. Childs Associates, L.P.
000 Xxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxxxxx, XX 00000
Attention: Xxxxxx X. Xxx
Telecopy: 617-753-1101
(b) For notices and communications to the Stockholders, to the
respective addresses or telecopy numbers set forth in the Schedule of
Stockholders.
(c) With a copy in the case of the JWC Holders and the Company
to:
Xxxx Xxxxxxx LLP
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
Attention: Xxxxxxx X. Xxxxx, Esq.
Telecopy: 000-000-0000
(d) With a copy in the case of the Halifax Holders to:
The Halifax Group, L.L.C.
0000 Xxxxxxxxxxx Xxxxxx, X.X.
Xxxxx 000
Xxxxxxxxxx, X.X. 00000
Attention: Xxxxx X. Xxxxxx and Xxxxxxx X.
Xxxxx
Telecopy: 000-000-0000
(e) With a copy in the case of the Management Holders to:
InSight Health Services Corp.
0000 XxxXxxxxx Xxxx., Xxxxx 000
Xxxxxxx Xxxxx, XX 00000
Attention: General Counsel and President
Telecopy: (000) 000-0000
By notice complying with the foregoing provisions of this Section 6.4, each
party shall have the right to change the mailing address or telecopy numbers for
future notices and communications to such Party.
6.5 Binding Effect; Assignment. This Agreement shall be binding upon
and inure to the benefit of the parties hereto and to their respective
transferees, successors, assigns, heirs and administrators, provided that the
rights under this Agreement may not be assigned except as expressly provided
herein. No such assignment shall relieve an assignor of its obligations
hereunder.
35
6.6 Termination. Without affecting any other provision of this
Agreement requiring termination of any rights in favor of any Stockholder,
Permitted Transferee or any other transferee of Common Stock Equivalents, the
provisions of Articles II and III (other than the indemnity and contribution
provisions set forth therein) of this Agreement shall terminate as to such
Stockholder, Permitted Transferee or other transferee, when, pursuant to and in
accordance with this Agreement, such Stockholder, Permitted Transferee or other
transferee, as the case may be, no longer owns any Common Stock Equivalents.
6.7 Recapitalizations, Exchanges, etc. The provisions of this Agreement
shall apply, to the full extent set forth herein with respect to Common Stock
Equivalents, to any and all shares of capital stock of the Company or any
successor or assign of the Company (whether by merger, consolidation, sale of
assets or otherwise) which may be issued in respect of, in exchange for, or in
substitution of the Common Stock Equivalents, by reason of a stock dividend,
stock split, stock issuance, reverse stock split, combination, recapitalization,
reclassification, merger, consolidation or otherwise. Upon the occurrence of any
such events, amounts (including the Cost Price) hereunder shall be appropriately
adjusted.
6.8 JWC Representative. Each JWC Holder hereby designates and appoints
(and each Permitted Transferee of each such JWC Holder shall be deemed to have
so designated and appointed) Xxxxxx X. Xxxxx and Xxxxxx X. Xxx (so long as they
are employees of X.X. Childs Associates, Inc. or its Affiliates or successor
entities), or either of them, with full power of substitution (the "JWC
REPRESENTATIVE") the representative of each such Person to perform all such acts
as are required, authorized or contemplated by this Agreement to be performed by
any such Person and hereby acknowledges that the JWC Representative shall be the
only Person authorized to take any action so required, authorized or
contemplated by this Agreement by each such Person. Each such Person further
acknowledges that the foregoing appointment and designation shall be deemed to
be coupled with an interest and shall survive the death or incapacity of such
Person. Each such Person hereby authorizes (and each Permitted Transferee shall
be deemed to have authorized) the other parties hereto to disregard any notice
or other action taken by such Person pursuant to this Agreement except for the
JWC Representative. The other parties hereto are and will be entitled to rely on
any action so taken or any notice given by the JWC Representative and are and
will be entitled and authorized to give notices only to the JWC Representative
for any notice contemplated by this Agreement to be given to any such Person. A
successor to the JWC Representative may be chosen by the holders of a majority
of the Common Stock Equivalents at the time held by the JWC Holders, provided
that written notice thereof is given by the successor JWC Representative to the
Company, the Halifax Holders, the Management Holders, the Additional Holders and
the other JWC Holders.
6.9 Halifax Representative. Each Halifax Holder hereby designates and
appoints (and each Permitted Transferee of each such Halifax Holder shall be
deemed to have so designated and appointed) Xxxxx X. Xxxxxx and Xxxxxxx X. Xxxxx
(so long as they are employees of Halifax Capital Partners or its Affiliates or
successor entities), or either of them, with full power of substitution (the
"HALIFAX REPRESENTATIVE") the representative of each such Person to perform all
36
such acts as are required, authorized or contemplated by this Agreement to be
performed by any such Person and hereby acknowledges that the Halifax
Representative shall be the only Person authorized to take any action so
required, authorized or contemplated by this Agreement by each such Person. Each
such Person further acknowledges that the foregoing appointment and designation
shall be deemed to be coupled with an interest and shall survive the death or
incapacity of such Person. Each such Person hereby authorizes (and each
Permitted Transferee shall be deemed to have authorized) the other parties
hereto to disregard any notice or other action taken by such Person pursuant to
this Agreement except for the Halifax Representative. The other parties hereto
are and will be entitled to rely on any action so taken or any notice given by
the Halifax Representative and are and will be entitled and authorized to give
notices only to the Halifax Representative for any notice contemplated by this
Agreement to be given to any such Person. A successor to the Halifax
Representative may be chosen by the holders of a majority of the Common Stock
Equivalents at the time held by the Halifax Holders, provided that written
notice thereof is given by the successor Halifax Representative to the Company,
the JWC Holders, the Management Holders, the Additional Holders and the other
Halifax Holders.
6.10 Action Necessary to Effectuate the Agreement. The parties hereto
agree to take or cause to be taken all such corporate and other action as may be
necessary to effect the intent and purposes of this Agreement.
6.11 No Waiver. No course of dealing and no delay on the part of any
party hereto in exercising any right, power or remedy conferred by this
Agreement shall operate as waiver thereof or otherwise prejudice such party's
rights, powers and remedies. No single or partial exercise of any rights, powers
or remedies conferred by this Agreement shall preclude any other or further
exercise thereof or the exercise of any other right, power or remedy.
6.12 Counterparts. This Agreement may be executed in two or more
counterparts (including Joinder Agreements as counterparts), each of which shall
be deemed an original, but all of which together shall constitute one and the
same instrument, and all signatures need not appear on any one counterpart.
6.13 Headings, etc. All headings and captions in this Agreement are for
purposes of references only and shall not be construed to limit or affect the
substance of this Agreement. Words used in this Agreement, regardless of the
gender and number used, will be deemed and construed to include any other
gender, masculine, feminine, or neuter, and any other number, singular or
plural, as the context requires. As used in this Agreement, the word "INCLUDING"
is not limiting, and the word "OR" is not exclusive. The words "THIS AGREEMENT",
"HERETO", "HEREIN", "HEREUNDER", "HEREOF", and words or phrases of similar
import refer to this Agreement as a whole, together with any and all Schedules
and Exhibits hereto, and not to any particular article, section, subsection,
paragraph, clause or other portion of this Agreement.
6.14 Governing Law; Jurisdiction; Service of Process. This Agreement
shall, in accordance with section 5-1401 of the General Obligations Law of the
State of New York, be governed by the laws of the State of New York, without
regard to any conflicts of laws principles
37
thereof that would call for the application of the laws of any other
jurisdiction. Any action or proceeding seeking to enforce any provision of, or
based on any right arising out of, this Agreement may be brought against either
of the parties in the courts of the State of New York, or if it has or can
acquire jurisdiction, in the United States District Court for the Southern
District of New York, and each of the parties hereby consents to the
jurisdiction of such courts (and of the appropriate appellate courts) in any
such action or proceeding and waives any objection to venue laid therein.
Process in any action or proceeding referred to in the preceding sentence may be
served on any party anywhere in the world, whether within or without the State
of New York.
6.15 Confidentiality; Public Announcements. No JWC Holder, Halifax
Holder, Management Holder or Additional Holder shall disclose or use in any
manner whatsoever, in whole or in part, any information concerning the Company
or any of its direct or indirect shareholders, or any of their respective
employees, directors or Subsidiaries or Affiliates (including, without
limitation, the JWC Holders) received on a confidential basis from the Company
or any other Person under or pursuant to this Agreement or any other agreement
with the Company including without limitation financial terms and financial and
organizational information contained in any documents, statements, certificates,
materials or information furnished, or to be furnished, by or on behalf of the
Company or any other Person in connection with the purchase or ownership of any
Common Stock Equivalent; provided, however, that the foregoing shall not be
construed, now or in the future, to apply to any information reflected in any
recorded document, information which is independently developed by such
Stockholder, information obtained from sources other than the Company or any of
its direct or indirect shareholders, or any of their respective employees,
directors, Subsidiaries or Affiliates (including without limitation the JWC
Holders) or any of their respective agents or representatives (including without
limitation attorneys, accountants, financial advisors, engineers and insurance
brokers) or information that is or becomes in the public domain, nor shall it be
construed to prevent such Stockholder from (i) making any disclosure of any
information (A) if required to do so by any statute, law, treaty, rule,
regulation, order, decree, writ, injunction or determination of any court or
other governmental authority, in each case applicable to or binding upon such
Stockholder, (B) to any governmental authority having or claiming authority to
regulate or oversee any aspect of such Stockholder business or that of the
corporate parent or affiliates of such Stockholder in connection with the
exercise of such authority or claimed authority, or (C) pursuant to subpoena; or
(ii) making, on a confidential basis, such disclosures as such Stockholder deem
necessary or appropriate to such Stockholder's legal counsel, accountants
(including outside auditors) or general or managing partner; (iii) making such
disclosures as such Stockholder reasonably deem necessary or appropriate to any
Transferee and/or counsel to or other representatives of such bank or financial
institution or other entity, to which such Stockholder in good faith desires to
Transfer all or a portion of its interest in any Common Stock Equivalents;
provided, however, that such Transferee or counsel to or representative thereof,
agree maintain the confidentiality of such disclosures on the terms stated
herein; or (iv) making, on a confidential basis, disclosures of such information
to current Stockholders.
[Signatures on Following Pages]
38
SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
COUNTERPART SIGNATURE PAGE
IN WITNESS WHEREOF, the parties have executed this Agreement as an
instrument under SEAL as of the date first set forth above.
THE COMPANY:
INSIGHT HEALTH SERVICES HOLDINGS CORP.
By: /s/ Xxxxxx X. Xxxxxxxxx
--------------------------------------------
Name: Xxxxxx X. Xxxxxxxxx
Title: President and Chief Executive Officer
SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
CONTINUATION OF COUNTERPART SIGNATURE PAGES
MANAGEMENT HOLDERS:
XXXXXX X. XXXXXXXXX
By: /s/ Xxxxxx X. Xxxxxxxxx
---------------------------------------
XXXXXXX X. XXXXXX
By: /s/ Xxxxxxx X. Xxxxxx
----------------------------------------
XXXXXX X. XXXXX
By: /s/ Xxxxxx X. Xxxxx
----------------------------------------
XXXXXXX X. XXXXXX
By: /s/ Xxxxxxx X. Xxxxxx
----------------------------------------
SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
CONTINUATION OF COUNTERPART SIGNATURE PAGES
THE JWC HOLDERS:
X.X. CHILDS EQUITY PARTNERS II, L.P.
By: X.X. Childs Advisors, L.P.
By: X.X. Childs Associates, L.P.
By: X.X. Childs Associates, Inc.
By: /s/ Xxxxxx X. Xxx
----------------------------------------
Name: Xxxxxx X. Xxx
Title: Vice President
JWC-INSIGHT CO-INVEST LLC
By: X.X. Childs Associates, Inc.
By: /s/ Xxxxxx X. Xxx
----------------------------------------
Name: Xxxxxx X. Xxx
Title: Vice President
By executing above, each of the foregoing JWC Holders acknowledges
that, pursuant to Section 6.8 of this Second Amended and Restated Stockholders
Agreement, each of the foregoing JWC Holders has designated and appointed Xxxxxx
X. Xxxxx and Xxxxxx X. Xxx, or either of them, as its representative to perform
all acts as are required, authorized or contemplated by this Second Amended and
Restated Stockholders Agreement.
SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
CONTINUATION OF COUNTERPART SIGNATURE PAGES
THE HALIFAX HOLDERS:
HALIFAX CAPITAL PARTNERS, L.P.
By: Halifax Genpar, L.P.
By: The Halifax Group, L.L.C.
By: /s/ Xxxxx X. Xxxxxx
----------------------------------------
Name: Xxxxx X. Xxxxxx
Title: Managing Partner
XXXXX X. XXXXXX
/s/ Xxxxx X. Xxxxxx
--------------------------------------------
By executing above, each of the foregoing Halifax Holders acknowledges
that, pursuant to Section 6.9 of this Second Amended and Restated Stockholders
Agreement, each of the foregoing Halifax Holders has designated and appointed
Xxxxx X. Xxxxxx and Xxxxxxx X. Xxxxx, or either of them, as its representative
to perform all acts as are required, authorized or contemplated by this Second
Amended and Restated Stockholders Agreement.
SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
CONTINUATION OF COUNTERPART SIGNATURE PAGES
ADDITIONAL HOLDER:
By:
----------------------------------------
Name:
EXHIBIT A
SCHEDULE OF STOCKHOLDERS
X.X. CHILDS EQUITY PARTNERS II, L.P.
c/o X.X. Childs Associates, L.P.
000 Xxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxxxxx, XX 00000
Attention: Xxxxxx X. Xxx
Telecopy: 617-753-1101
JWC-INSIGHT CO-INVEST LLC
c/o X.X. Childs Associates, L.P.
000 Xxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxxxxx, XX 00000
Attention: Xxxxxx X. Xxx
Telecopy: 617-753-1101
HALIFAX CAPITAL PARTNERS, L.P.
c/o The Halifax Group, L.L.C.
0000 Xxxxxxxxxxx Xxxxxx, X.X.
Xxxxx 000
Xxxxxxxxxx, X.X. 00000
Attention: Xxxxx X. Xxxxxx and Xxxxxxx X. Xxxxx
Telecopy: 000-000-0000
XXXXX X. XXXXXX
c/o The Halifax Group, L.L.C.
0000 Xxxxxxxxxxx Xxxxxx, X.X.
Xxxxx 000
Xxxxxxxxxx, X.X. 00000\
Telecopy: 000-000-0000
EXHIBIT B
JOINDER AGREEMENT
The undersigned is executing and delivering this Joinder Agreement
pursuant to the Second Amended and Restated Stockholders' Agreement, dated as of
February 8, 2002 (the "SECOND AMENDED AND RESTATED STOCKHOLDERS' AGREEMENT"),
among InSight Health Services Holdings Corp., a Delaware corporation (the
"COMPANY"), the JWC Holders, Halifax Holders, Management Holders and Additional
Holders named therein.
By executing and delivering this Joinder Agreement to the Company, the
undersigned hereby agrees to become a party to, to be bound by, and to comply
with the provisions of the Second Amended and Restated Stockholders' Agreement
in the same manner as if the undersigned were an original signatory to such
agreement as a Management Holder. In connection therewith, effective as of the
date hereof the undersigned hereby makes the representations and warranties
contained in the Second Amended and Restated Stockholders' Agreement.
Accordingly, the undersigned has executed and delivered this Joinder
Agreement as of the 25 day of February, 2002.
/s/ Xxx Xxxxxx
---------------------------------
Signature of Stockholder
Xxx Xxxxxx
---------------------------------
Print Name of Stockholder
